Dissertations / Theses on the topic 'Islands of Langerhans'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 dissertations / theses for your research on the topic 'Islands of Langerhans.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
Ar'Rajab, Aamer. "Islet transplantation in the treatment of diabetes number of islets, functional regulation and metabolic control /." Lund : Dept. of Surgery, Lund University, 1991. http://catalog.hathitrust.org/api/volumes/oclc/38187937.html.
Full textAxcrona, Ulrika Myrsén. "Expression and regulation of neuropeptide Y (NPY) in the Islets of Langerhans." Lund : Dept. of Physiology and Neuroscience, Section for Neuroendocrine Cellbiology, Lund University, 1997. http://books.google.com/books?id=Ew5rAAAAMAAJ.
Full textEdwin, Nalini. "Quantitative estimation of islet tissue of pancreas in Australian mammals (comparative histological study) /." Title page, contents and summary only, 1986. http://web4.library.adelaide.edu.au/theses/09PH/09phe269.pdf.
Full textKulis, Michael D. "Islet neogenesis associated protein-related protein from gene to folded protein /." Available online, Georgia Institute of Technology, 2006, 2006. http://etd.gatech.edu/theses/available/etd-01112006-195113/.
Full textShuker, Suzanne, Committee Chair ; Doyle, Donald, Committee Member ; Orville, Allen, Committee Member ; Barry, Bridgette, Committee Member ; McCarty, Nael, Committee Member.
Blais, Debbie Lin Marie. "Becoming an islet cell allotransplant recipient." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp04/mq21258.pdf.
Full textYan, Mengyong. "Interaction of human papillomavirus-like particles with dendritic cells and Langerhans cells : involvement in uptake, activation and cross-presentation /." St. Lucia, Qld, 2003. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe17614.pdf.
Full textTeague, Warwick J. "Mesenchyme-to-epithelial transition in pancreatic organogenesis." Thesis, University of Oxford, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.670115.
Full textIovino, Giugetta. "The role of lipid peroxidation in pancreatic islet function and destruction in Type 1 diabetes mellitus." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp01/MQ37131.pdf.
Full textWu, Douglas Ching Gee. "Cellular therapeutic strategies for the treatment of Type 1 Diabetes Mellitus." Thesis, University of Oxford, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.670111.
Full textSerra, Navarro Berta. "Implicació de la senyalització dependent de Gsα en l’establiment de la massa cel·lular β." Doctoral thesis, Universitat de Barcelona, 2018. http://hdl.handle.net/10803/667060.
Full textWilson, John Tanner. "Biomolecular strategies for cell surface engineering." Diss., Georgia Institute of Technology, 2009. http://hdl.handle.net/1853/33846.
Full textJackson, Andrew M. Naziruddin Bashoo. "Analysis of inflammatory changes in human pancreatic islet cells." Waco, Tex. : Baylor University, 2009. http://hdl.handle.net/2104/5344.
Full textAlves, Figueiredo Hugo Jorge. "Improving islet-graft revascularization." Doctoral thesis, Universitat de Barcelona, 2018. http://hdl.handle.net/10803/586309.
Full textIslet transplantation is considered a potentially curative treatment for type 1 diabetes, Despite the key important advances achieved by the establishment of the Edmonton protocol, islet transplantation remains clinically limited due to several challenges, which lead to massive islet loss or failure of the grafts. Therefore searching for new targets to facilitate islet revascularization may lead to improved future results in cell transplantation.Islets native architecture is characterized by a dense vessel network that, delivers oxygen, hormones, glucose, and nutrients to islet’s cells allowing them to function correctly. After transplantation, the survival and function of islet grafts must depend on the reestablishment of new vessels within the grafts to derive blood flow from the host vascular system. This vascular network is severed when islets are isolated for transplantation, and even though islets freely revascularize, they do not reach the levels of vascularization present in endogenous pancreatic islets, which results in the impairment of grafts function and survival. Altogether, the lack of a proper vascular network account as the primary responsible for early graft loss. Although the molecular mechanisms underlying islet revascularization remain elusive, a number of factors have been implicated, such as the vascular endothelial growth factor A (VEGFA), a key angiogenic molecule that acts to stimulate new vessel formation. VEGFA expression in transplanted islets is significantly impaired, which is further pronounced in prevailing hyperglycemia, and coincides with delayed and insufficient islet revascularization in diabetic mice In this thesis we identify for the first time, tyrosine phosphatase PTP-1B as a target for improving graft revascularization. We targeted PTP-1B, either by its inhibition, following a sodium tungstate treatment after transplantation, or by transplanting islets lacking PTP-1B, using a genetic model of PTP-1B knock-out, or following genetic silencing, using siRNA and shRNA Lentivirus particles. Following transplantation into the anterior chamber of the eye in diabetic mice, islet-grafts showed increased revascularization by inducing the expression of VEGF-A by ß-cells in the graft. This improved revascularization was followed by an improvement of islet-graft survival and function, as transplanted mice recovered normoglycemia and glucose tolerance. Furthermore, we demonstrated that PTP-1B induces VEGF-A expression and secretion in islets by upregulating HIF1A-independent PGC1α/ERRα signaling. Finally, we demonstrated that this regulatory mechanism is conserved in human islets. Together, these findings unravel the potential role of PTP-1B as a target for improving islet transplantation outcomes.
Filiputti, Eliane. "Regulação da secreção de insulina em ilhotas de Langerhans de ratos submetidos a restrição proteica e suplementados com leucina." [s.n.], 2006. http://repositorio.unicamp.br/jspui/handle/REPOSIP/314197.
Full textTese (doutorado) - Universidade Estadual de Campinas, Instituto de Biologia
Made available in DSpace on 2018-08-06T11:23:18Z (GMT). No. of bitstreams: 1 Filiputti_Eliane_D.pdf: 3662221 bytes, checksum: e40ea0446558f8556a8352fd8c98a5fc (MD5) Previous issue date: 2006
Resumo: Suspeita-se que a desnutrição intra-uterina e pós-natal produzam mudanças morfológicas e funcionais no pâncreas endócrino e em tecidos periféricos, que se traduzem em insulinopenia e resistência à insulina. Baseado nessas complicações avaliou-se neste trabalho a regulação da secreção de insulina em ilhotas de Langerhans de ratos e camundongos submetidos à restrição protéica e suplementados com leucina. A suplementação com leucina não modificou hábitos alimentares, ingestão hídrica e o peso corpóreo dos animais em estudo, mas alterou parâmetros bioquímicos importantes como glicose (G), ácidos graxos (AGL) em animais desnutridos. A fosforilação do receptor de insulina (IR) e de seu substrato (IRS-l) foi modificada em fígado e músculo levando a uma melhoria na homeostasia glicêmica em ratos desnutridos, a metabolismo de glicose em ilhotas de ratos controle e desnutridos teve redução após suplementação, a potencial de membrana das células B foi restaurado, o movimento de cálcio citoplasmático e a secreção de insulina estimulada por G e leucina apresentaram aumentados em ilhotas de ratos e camundongos desnutridos. Alterações ocorreram também no perfil eletroforético de proteínas citoplasmáticas após suplementação com leucina em ilhotas de ratos. Expressão gênica e protéica de proteínas chaves na cascata de sinalização de insulina como IR, IRS-l, PI3K, mTaR e S6K-l se alteraram em resposta à suplementação com leucina em ilhotas de ratos desnutridos, favorecendo vias de crescimento, em especial o aumento da PI3K a qual resultou em aumento de sua atividade em ilhotas de ratos controle e desnutridos. Por fim, podemos concluir que a suplementação com leucina promoveu modulação da sensibilidade periférica em fígado e músculo de maneira tecido específica. Isto confere uma regulação da homeostase glicêmica de maneira distinta entre animais controle e desnutridos suplementados. Além disso, direcionam para que os sinais metabólicos produzidos pela leucina devam promover seus efeitos, em ilhotas de Langerhans, via dois sensores: a GDH que controla a glutaminólise, e por outro lado está a PI3K que deve exercer seu papel, ativando vis envolvidas com a síntese protéica através da mTOR. Estes dois sensores devem atuar sinergicamente participando do rearranjo da concentração citosólica dos íons cálcio, principalmente em ilhotas de animais desnutridos que foram suplementados com leucina
Abstract: We think that intra-uterine mal nutrition and after birth produce morphological and changes in endocrine pancreas and in peripheric tissue that translate insulinopenia and insulin resistance. Based on these complications we have evaluated in this work the insulin secretion regulation in Langerhans islets from rats and mice fed a low protein diet and supplemented with leucine. The leucine supplementation hasn't changed the diet in the hybrid ingest and body weight but has changed important biochemistry standards as glucose (G) and FFA in malnutrition animals. The insulin receptor phosphorilation and its substract have been changed in liver and musc1e leading to an increase in glicemic homeostase in malnutrition rats. The glucose metabolism in control and malnutrition rats' islets had one reduction after supplementation. B cells potential membranes were restored; the citoplasmatic ca1cium movement and insulin secretion were stimulated by glucose and leucine. They have showed an increased in islets of control and malnourished rats and mice islets. Some alterations have also occurred in the citoplasmatic protein eletrophoretic profile after leucine supplementation in rats islets. The genetic and protein expression from key enzymes in the insulin cascade signalization as: IR; IRS-l; PI3K; mTOR and S6K-l have altered in leucine supplementation answer in malnutrition islets rats favoring growth pathways specially PI3K increase which resulted in an increasement of control and malnutrition rats islets activity. In the end we can conc1ude that the leucine supplementation has promoted peripheric sensibilization in liver and muscle in specific tissue manner. This confirms one glicemic homeostase regulation in distinct manner among control and malnutrition both supplemented animals. Furthermore they lead the metabolic signals produced by leucine should promote their effects in Langerhans islets throw sensor ways: GDH which controls glutaminolisis and on the otherhand is PI3K that should do its role activating growth pathways throw mTOR. These two sensors should work in synergism participating in citosolic concentration changes of ca1cium ions mainly in malnutrition animals' islets, which were supplemented.
Doutorado
Fisiologia
Doutor em Biologia Funcional e Molecular
Arantes, Vanessa Cristina. "Acido graxo aumenta a secreção de insulina e modula a expressão de genes envolvidos na biossintese de insulina em ilhotas de ratos submetidos a desnutrição proteica." [s.n.], 2006. http://repositorio.unicamp.br/jspui/handle/REPOSIP/313938.
Full textTese (doutorado) - Universidade Estadual de Campinas, Instituto de Biologia
Made available in DSpace on 2018-08-06T07:06:58Z (GMT). No. of bitstreams: 1 Arantes_VanessaCristina_D.pdf: 1696436 bytes, checksum: 2db258b560bf7ee0ec64de7441adfe76 (MD5) Previous issue date: 2006
Resumo: Em animais, a desnutrição intra-uterina exerce efeitos marcantes sobre o desenvolvimento fetal e pós-natal. Sabe-se que animais desnutridos apresentam níveis elevados de ácidos graxos plasmáticos e esses, por sua vez, são responsáveis por alterar a secreção de insulina. Neste trabalho, verificamos a expressão do fator de transcrição PDX-1, da p38/SAPK2, o metabolismo da glicose e a secreção de insulina em ilhotas de ratos mantidos durante o período fetal e da lactação com uma dieta normoprotéica (17% de proteína) ou hipoprotéica (6% de proteína). Cultivamos as ilhotas por 48 horas em meio de cultura contendo 5.6 mM/L de glicose, na ausência ou presença de0.6 mM/L de ácido palmítico. A secreção de insulina em ilhotas isoladas em resposta 16,7 mmol/L de glicose foi reduzida em ratos desnutridos, no entanto, quando na presença de ácido graxo, observou-se um aumento. Em 2.8 mmol glicose/L,houve diminuição do metabolismo da glicose em ilhotas de desnutridos .Entretanto, quando estimuladas com 16.7 mmol/L de glicose, tanto as ilhotas de desnutridos como as do controle, apresentaram acentuada redução na oxidação da glicose, na presença de ácido graxo. Os níveis de mRNA do PDX-1 e da insulina aumentaram significativamente quando na presença de ácido graxo em ambos os grupos. O efeito do ácido palmítico sobre a expressão protéica de PDX-1 e da p38/SAPK2 apresentou-se similar em ambos os grupos, mas o aumento foi muito mais evidente em ilhotas de desnutridos. Esses resultados demonstram a complexa relação entre nutrientes no controle da secreção de insulina e mostram queos ácidos graxos desempenham um papel importante na homeostasia da glicose, por afetar mecanismos moleculares e as vias de acoplamentsecreção de insulina
Abstract: A severe reduction in insulin release in response to glucose is consistently noticed in protein-deprived rats and is attributed partly to the chronic exposure to elevated levels of free fatty acids. Since the pancreatic and duodenal transcription factor homeobox 1 (PDX-1) is important for the maintenance of B-cell physiology, and since PDX-1 expression is altered in the islets of rats fed a low protein diet, we assessed PDX-1 and insulin mRNA expression, as well as PDX-1 and p38/SAPK2 protein expression, in islets from young rats fed low (6%; LP) or normal (17%; C) protein diets and maintained for 48 h in culture medium containing 5.6 mmol glucose/L with or without 0.6 mmol palmitic acid/L. We also measured glucoseinduced insulin secretion and glucose metabolism. Insulin secretion by isolated islets in response to 16.7 mmol glucose/L was reduced in LP compared to C rats. In the presence of free fatty acids, there was an increase in insulin secretion in both groups At 2.8 mmol glucose/L, the metabolism of this sugar was reduced in LP islets, regardless of the presence of this fatty acid. However, when challenged with 16.7 mmol glucose/L, LP and C islets showed a severe reduction in glucose oxidation in the presence of free fatty acid. The PDX-1 and insulin mRNA were significantly higher when free fatty acid was added to the culture medium in both groups of islets.The effect of palmitic acid on PDX-1 and p38/SAPK2 protein levels was similar in LP and C islets, but the increase was much more evident in LP islets. These results demonstrate the complex interrelationship between nutrients in the control of insulin release and support the view that fatty acids play an important role in glucose homeostasis by affecting molecular mechanisms and stimulus/secretion coupling pathways
Doutorado
Fisiologia
Doutor em Biologia Funcional e Molecular
Quallio, Silvana. "Avaliação da função e plasticidade celuar de ilhotas pancreaticas em modelo de resistencia a insulina induzida por dexametosa em ratos." [s.n.], 2008. http://repositorio.unicamp.br/jspui/handle/REPOSIP/314399.
Full textDissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia
Made available in DSpace on 2018-08-11T17:39:01Z (GMT). No. of bitstreams: 1 Quallio_Silvana_M.pdf: 957537 bytes, checksum: 0c375a9b9290585b85244a414a6ea02d (MD5) Previous issue date: 2008
Resumo: Introdução e objetivos: O aumento nos níveis de glicose circulante é o principal estímulo para a secreção de insulina. A insulina se liga a receptores de membrana desencadeando diversas respostas celulares. Qualquer alteração na sensibilidade à insulina pode levar a disfunções fisiológicas como a resistência à insulina observada em pacientes diabéticos tipo 2 (T2DM). Experimentalmente, essa condição patológica pode ser mimetizada pela administração de altas doses de glicocorticóides, provendo assim um bom modelo para seu estudo. O objetivo do presente trabalho foi avaliar a plasticidade das ilhotas pancreáticas submetidas à variação na necessidade secretória de insulina por indução de resistência periférica ao hormônio por tratamento com dexametasona e posterior interrupção do tratamento. Métodos: Ratos wistar com 90 dias de vida foram tratados com dexametasona (1mg/kg, ip) por 5 dias consecutivos (DEX). Em outro grupo (DEX10), os animais foram tratados da mesma maneira e avaliados 10 dias após o último dia da administração de dexametasona. Ratos controle (CTL) receberam administração de NaCl 0,9% apenas. As ilhotas foram isoladas pelo método da colagenase. A expressão de proteínas foi feita por immunoblotting. As análises morfométricas foram realizadas microscopicamente. Resultados: O grupo DEX exibiu marcante resistência periférica à insulina, que foi revertida após o período de 10 dias no grupo DEX10. As ilhotas do grupo DEX apresentaram alterações funcionais e morfológicas como aumento da secreção de insulina estimulada por secretagogos, da área, da densidade e tendência de aumento na massa de células ß ao contrário do grupo DEX10. O conteúdo de proteínas relacionadas ao ciclo celular como a CD2 e CDK4 e a fosforilação da AKT aumentou em ilhotas do grupo DEX, mas retornou aos níveis do CTL em ilhotas DEX10. Conclusão: Estes resultados mostram a plasticidade do pâncreas endócrino haja vista a habilidade de se adaptar a situações que exigem maior ou menor demanda de insulina
Abstract: Introduction and aims: Insulin binds to plasma membrane receptors leading to a variety of cellular responses. Malfunction in any of the insulin cell signalling pathways in target tissues may lead to several conditions and diseases, like hyperglycemia, insulin resistance and type 2 diabetes mellitus (T2DM). These effects may be experimentally reproduced using high doses of glucocorticoids, providing thus a good model for the study of T2DM. The aims of this study were to evaluate the plasticity of pancreatic islets subject to variation on the need for insulin secretory induction of peripheral resistance to the hormone by treatment with dexamethasone and subsequent treatment interruption. Methods: Male wistar rats (90 days old) were treated with dexamethasone (1mg/kg, ip) for 5 consecutive days (DEX). In another group (DEX10), the animals were treated in the same way and assessed 10 days after the last day of administration. Control rats (CTL) received equivalent volume of vehicle. Protein expression was assayed trough immunoblotting. Morphometric analyses were done using a optical microscope and specific digital analysis programs. Results: DEX group showed marked peripheral insulin resistance, reverted after the recovering period in the DEX10 group. DEX islets showed functional and morphological changes, like increased insulin secretion, superficial area, population density, and a tendency for increase in the total mass content of beta cell. Cell cycle proteins CD2 and CDK4 and AKT phosphorylation were increased in the DEX group when compared to CTL group. All these effects were reverted in the group DEX10. Conclusions: These results show that the endocrine pancreas possess a plasticity regarding the capacity of pancreatic islets to adapt themselves to situations where a higher or lower demand for insulin is needed.
Mestrado
Fisiologia
Mestre em Biologia Funcional e Molecular
Wong, Jeffrey K. W. "Chemokines and chemokine receptors in islet xenograft rejection." Thesis, The University of Sydney, 2006. https://hdl.handle.net/2123/28055.
Full textAtla, Goutham. "Dissecting genetic regulatory mechanisms in human pancreatic islets to gain insights into type 2 diabetes pathophysiology." Doctoral thesis, Universitat de Barcelona, 2021. http://hdl.handle.net/10803/672647.
Full textPhelps, Edward Allen. "Bio-functionalized peg-maleimide hydrogel for vascularization of transplanted pancreatic islets." Diss., Georgia Institute of Technology, 2011. http://hdl.handle.net/1853/45899.
Full textRibeiro, Rosane Aparecida. "Regulação da secreção de insulina em ilhotas pancreaticas de camundongos suplementados com taurina." [s.n.], 2009. http://repositorio.unicamp.br/jspui/handle/REPOSIP/314748.
Full textTese (doutorado) - Universidade Estadual de Campinas, Instituto de Biologia
Made available in DSpace on 2018-08-13T09:09:25Z (GMT). No. of bitstreams: 1 Ribeiro_RosaneAparecida_D.pdf: 2339564 bytes, checksum: 146ea5a2123d76628db5f4758417e020 (MD5) Previous issue date: 2009
Resumo: Neste estudo, investigamos os efeitos da suplementação com taurina (TAU; 2% adicionada à água de beber) sobre a tolerância à glicose e a secreção de insulina frente a diferentes secretagogos em camundongos adultos. Camundongos suplementados apresentaram aumento da tolerância à glicose e da sensibilidade à insulina. Ilhotas isoladas destes animais secretaram mais insulina em resposta à glicose e L-leucina. A oxidação da L-leucina foi maior no grupo TAU, não havendo diferenças quanto ao consumo de glicose, concentrações de ATP e expressão do transportador da glicose (GLUT) 2 e da glicoquinase (GCK). A captação de Ca2+, na presença de glicose, e a expressão protéica da subunidade ß2 do canal de Ca2+ sensível à voltagem foi maior no grupo TAU comparado ao controle (CTL). Ainda, a expressão protéica da PL (fosfolipase) C ß 2 e da PK (proteína quinase) Aa, bem como a secreção de insulina em resposta a agentes potencializadores tais como carbacol (Cch) e IBMX, foi maior nas ilhotas TAU. A mobilização intracelular de Ca2+ induzida por Cch foi também maior em ilhotas deste grupo, e observamos que a inibição da PKA reduziu a captação de Ca2+ em resposta à glicose no grupo suplementado. Além disso, ilhotas TAU secretaram mais glucagon em relação a ilhotas CTL, quando em presença de baixa concentração de glicose. Concluindo, a suplementação com TAU melhora a homeostase glicêmica e aumenta a secreção de insulina de ilhotas isoladas e incubadas na presença de nutrientes e agentes potencializadores da secreção. Os efeitos sobre a secreção estão relacionados ao melhor manejo dos íons Ca2+ pelas células insulares provenientes dos animais suplementados com TAU.
Abstract: In this study, we investigated the effects of taurine (TAU)-supplementation (2% in the drinking water) on glucose tolerance and insulin secretion stimulated by different secretagogues in adult mice. TAU-supplemented mice showed enhanced glucose tolerance and insulin sensitivity when compared to controls (CTL). In addition, their islets secreted more insulin in response to high concentrations of glucose and L-leucine. L-[U-14C]leucine oxidation was higher in TAU islets compared with CTL islets, whereas D-[U-14C]glucose oxidation, ATP levels, and the protein expression of the glucose transporter (GLUT) 2 and of glucokinase (GCK) were similar. 45Ca uptake induced by high glucose concentrations was increased in TAU islets as well as the expression of the ß2 subunit of the L-type Ca2+ channel. In addition, the insulin secretion induced by carbachol (Cch) and IBMX, but not, by forskolin and PMA was higher in TAU-supplemented compared with CTL islets. The higher insulin secretion in the presence of Cch is accompanied by an increase in the expression of PL (phospholipase) C ß 2 protein and a higher intracellular Ca2+ mobilization. Besides, TAU-supplemented islets showed increased PK (protein kinase) Aa expression. Since the increase in Ca2+ uptake induced by glucose in TAU islets was minimized by the presence of the PKA inhibitor, H89, this kinase seems to be important for the better Ca2+ handling in these islets. TAUsupplementation also turns the a-cells more sensitivity since these cells secreted more glucagons compared with CTL islets. In conclusion, TAU supplementation enhances glucose tolerance and insulin sensitivity in mice and turns the islets more sensitive to nutrients and to potentiators of secretion. The effect on insulin secretion seems to be linked to a better Ca2+ handling by ß-cells.
Doutorado
Fisiologia
Doutor em Biologia Funcional e Molecular
Wang, Xiao Yang. "Approaches to induce islet allograft tolerance by liver allografting and to improve fetal pig islet function by gut hormones." Thesis, The University of Sydney, 1999. https://hdl.handle.net/2123/27740.
Full textCadavez, Trigo Lisa. "Islet amylold in type 2 diabetes: The role of chaperones in endoplasmic reticulum stress and amyloid formation in pancreatic β-cell." Doctoral thesis, Universitat de Barcelona, 2014. http://hdl.handle.net/10803/290734.
Full textVelasco, Mallorquí Ferran. "Carboxymethyl cellulose-based cryogels as scaffolds for pancreatic and skeletal muscle tissue engineering." Doctoral thesis, Universitat de Barcelona, 2021. http://hdl.handle.net/10803/672378.
Full textLa incidència de la diabetis ha augmentat considerablement en els últims anys. Segons l’IDF (International Diabetes Federation), al 2019 hi havia 463 milions de persones que patien diabetis i les estimacions estimen un augment considerable de casos, arribant als 700 milions de persones diabètiques cap al 2045 [1]. Entre els diferents tipus de diabetis, la diabetis tipus 2, és la que té major incidència en la població, corresponent al 90% dels casos de pacients amb diabetis. Aquest tipus de diabetis, succeeix quan el cos es torna resistent a la insulina. Aquesta resistència a la insulina per part dels teixits perifèrics ens prova que la diabetis no és només una malaltia del pàncreas, sinó que hi ha altres teixits relacionats, com el fetge, el teixit adipós o el múscul esquelètic. Aquest últim té un factor molt rellevant en la homeòstasi de la insulina i la glucosa, ja que és un dels principals teixits consumidors de glucosa. La interacció, però, entre aquest dos teixits encara presenta molts interrogants. Actualment, per estudiar com dos teixits interactuen entre ells, el testeig animal és el mètode més confiable. No obstant, presenta certes limitacions, com la poca similitud en quan a l’activitat dels illots, la variabilitat fisiològica entre diferents animals, dilemes ètics o la necessitat d’encarar la recerca cap a una medicina més personalitzada. Aquesta finalitat és el que ha portat als científics a buscar alternatives a l’experimentació animal. Entre moltes, una de les més prometedores són els anomenats Òrgans-en-un-xip, plataformes 3D de cultiu cel·lular combinades amb microfluídica i biomaterials que permeten simular les funcions específiques d’un òrgan. Per tal de generar el teixit dins d’aquesta plataforma, l’encapsulació de cèl·lules dins de hidrogels és la tècnica més utilitzada, degut al seu alt contingut d’aigua, la seva adaptabilitat mecànica o la possibilitat de generar una certa estructura geomètrica [2]. No obstant, la seva petita porositat, limita la difusió homogènia d’oxigen i de nutrients dins seu [3]. Aquest problema creix quan es volen encapsular illots pancreàtics en bastides d’hidrogel, degut a la seva mida (~100 μm de diàmetre). Els illots pancreàtics són agregacions de varis tipus diferent de cèl·lules, on destaquen les cèl·lules secretores de insulina (cèl·lules beta) i les secretores de glucagó (cèl·lules alfa). Per altre costat, el teixit muscular s’encapsula en petits constructes per tal d’imitar l’estructura d’aquest. El múscul esquelètic és un teixit altament alineat, amb cèl·lules multi nucleades, anomenades miotubs, que s’obtenen a partir de la fusió de cèl·lules soles, anomenades mioblasts. Per tal de solucionar aquests problemes, els criogels han aparegut com a alternativa. Els criogels, estan fabricats a temperatures sota zero, així mentres el polímer crosslinca es formen cristalls de gel. Un cop formada la matriu, la bastida es descongela i aquests cristalls es desfaran, deixant pas a espais buits, anomenats pors. Aquests, seran els que posteriorment li donaran la l’estructura porosa, altament interconnectada, amb alta permeabilitat i amb una arquitectura de pors determinada a la nostra bestida. En aquesta tesi s’han desenvolupat dos bastides de cel·lulosa carboxymetilada diferents seguint la tècnica de la criogelificació. Cada bastida ha estat dissenyada per tenir una distribució i una arquitectura de pors diferent d’acord amb la necessitat i propietat del teixit que es vulgui generar. A més, les propietats físiques i mecàniques de les dos bastides tenen alta semblança amb les propietats físiques i mecàniques de la matriu extracel·lular de cada teixit. Per el teixit pancreàtic, s’ha generat una bastida amb un diàmetre de pors similar als illots pancreàtics, per tal que, sembrant cèl·lules beta, aquestes formin pseudoillots similars als illots fisiològics. A més, s’ha demostrat que aquests illots tenen el diàmetre i la arquitectura desitjada, són viables i capaços de respondre a diferents nivells de glucosa. A més, s’ha demostrat que aquestes cèl·lules agregades en forma de pseudoillots responen millor a la glucosa que les cèl·lules configurades en distribució dispersa. En el cas del múscul esquelètic, s’ha desenvolupat una bastida amb una arquitectura de pors altament alineada per promoure l’alineament cel·lular i la fusió cel·lular. A més, s’han pogut incorporar nanotubs de carboni per millorar les propietats elèctriques de la vestida. D’aquesta manera, aplicant pulsos elèctrics per estimular el teixit, s’han pogut millorar les etapes primerenques de la maduració miogènica.
Roma, Leticia Prates. "Analise da expressão genica e proteica de ilhotas de ratos tratados com dexametasona." [s.n.], 2006. http://repositorio.unicamp.br/jspui/handle/REPOSIP/314401.
Full textDissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia
Made available in DSpace on 2018-08-06T10:10:15Z (GMT). No. of bitstreams: 1 Roma_LeticiaPrates_M.pdf: 861159 bytes, checksum: 232359e1de6e654ce6bb13758ca58bd2 (MD5) Previous issue date: 2006
Resumo: As células B pancreáticas possuem controle multifatorial que permite a secreção de insulina em quantidade e tempo adequados. Os glicocorticóides modulam a secreção de insulina dependendo do tempo e dose em que forem utilzados. Assim,o presente trabalho teve por objetivo analisar as alterações na expressão gênica e protéica de ilhotas de ratos tratados com dexametasona (1mg/kg, 5dias). Utilizando a técnica de cDNA Macroarray observamos que dos 1176 genes presentes na membrana, 66 tiveram sua expressão aumentada e 38 genes tiveram sua expressão diminuída. Os genes com expressão aumentada pertencem às vias de estresse celular (JNK1), inibidores do ciclo celular (p21) e vias de apoptose (Baxa e Fas). Os genes com expressão diminuída pertencem ao ciclo celular (ciclinas D1 e D2, CDK4) e vias de sinalização PI3K, AKT1 e P70. Demonstramos também aumento na expressão protéica da Bax a, redução na expressão da proteína anti-apoptótica Bcl-2, PI3K e P70. Animais tratados com dexametasona por 5 dias possuem níveis plasmáticos aumentados de insulina, triglicérides e ácidos graxos livres. Ilhotas isoladas de animais tratados com dexametasona por 5 e 10 dias apresentaram maior secreção de insulina em relação aos controles, em concentrações basais e estimulatórias de glicose e 40mM de potássio. Porém, o tratamento por 10 dias com dexametasona induziu diminuição na secreção de insulina quando comparado aos animais tratados por 5 dias. Nossos dados sugerem o tratamento com dexametasona pode modular (direta ou indiretamente) a expressão de diversos genes e proteínas envolvidas na apoptose e sobrevivência de células na ilhota pancreática. Essa modulação pode, em longo prazo, se refletir na secreção de insulina como visto nos animais tratados por 10 dias
Abstract: Insulin secretion from pancreatic B-cells is regulated by nutrients like glucose and amino acids and by neurotransmitters, and hormones. Since glucocorticoids modulate insulin secretion we investigated the effects of dexamethasone on gene and protein expression in pancreatic islets from rats treated with the glucocorticoid for 5 days (mg/kg/day). Using cDNA array analysis we found that, out of 1176 genes presented in the array, 66 were up-regulated and 38 down-regulated after dexamethasone treatment. RT-PCR confirmed the macroarray results for 4 genes whereas the expression of these transcripts was confirmed by Western blotting for the corresponding proteins. Many of the up-regulated genes are implicated in apoptosis (Bax a, Fas), cell cycle regulation (p21) and stress response (JNK1) whereas many of the down-regulated were involved in cell cycle progression (cyclins D1 and D2, and CDK4), and survival and proliferations pathways (PI3K, AKT, P70). The protein expression of Bax a was increased whereas Bcl-2, PI3K and P70 repressed. The rats treated with dexamethasone for 5 days showed higher insulin, triglicerides and free fatty acids plasma levels than controls. The insulin secretion, in response to glucose and high concentrations of K+, in islets isolated from dexamethasone-treated rats for 5 and 10 days was higher than control rats. However, after 10 days of treatment with dexamethasone the insulin secretion was lower than after 5 days, but still higher than controls. In conclusion, these data indicate that dexamethasone-treatment (directly or indirectly) modulates the expression of several genes and proteins involved in apoptosis and survival of pancreatic islet-cells, and could, thereafter, modulates the insulin secretion in rats treated for 10 days
Mestrado
Fisiologia
Mestre em Biologia Funcional e Molecular
Silva, Kelly Elizeu da. "INGAP-PP (Islets Neogenesis Associated Protein) aumenta a expressao das proteinas do canal de potassio, sensivel ao ATP, em ilhotas cultivadas de ratos adultos." [s.n.], 2007. http://repositorio.unicamp.br/jspui/handle/REPOSIP/313923.
Full textDissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia
Made available in DSpace on 2018-08-09T03:49:57Z (GMT). No. of bitstreams: 1 Silva_KellyElizeuda_M.pdf: 1866524 bytes, checksum: 87ae185f2da61d551d322f4375943e54 (MD5) Previous issue date: 2007
Resumo: O INGAP-PP é um pentadecapeptídeo constituído pela seqüência de aminoácidos do resíduo 104 ao 118 do INGAP (Islet Neogenesis Associated Protein), o qual é expresso no pâncreas exócrino e também nas células ductais durante a neogênese de células ßpancreáticas. Nesse trabalho, analisamos o efeito do tratamento crônico (4 dias) com INGAP-PP sobre a secreção de insulina, expressão gênica e protéica das subunidades Kir6.2 e SUR1 que formam o canal de K+ATP e do fator de transcrição Foxa2 (regulador da expressão das subunidades desse canal), em ilhotas isoladas de ratos adultos. As ilhotas tratadas com INGAP-PP (10 µg/mL) secretaram significativamente mais insulina quando incubadas por 1 h em concentrações entre 2.8 e 22.2 mM de glicose em comparação às ilhotas controles. Resultados de RT-PCR mostram que ilhotas tratadas com INGAP-PP tiveram expressão gênica do Foxa2 e das subunidades SUR1 e Kir6.2 aumentada. A expressão das proteínas SUR1 e Foxa2, analisada por Western Blotting, também foi maior nas ilhotas tratadas com INGAP-PP. Quando perfundidas na presença de 22,2 mM de glicose o aumento da secreção de insulina pelas ilhotas tratadas se manifestou com um primeiro pico secretor significativamente maior do que as ilhotas controles. Em presença de 2,8 mM de glicose, ilhotas tratadas com INGAP-PP secretaram mais insulina frente à concentrações despolarizantes de KCl ou tolbutamida (100 µM). Entretanto, a secreção de insulina estimulada por tolbutamida não diferiu entre os grupos em presença de 22,2 mM de glicose. A análise do efluxo de 86Rb mostrou que as ilhotas cultivadas com INGAP-PP apresentam menor efluxo do isótopo em relação às controle. Portanto, a maior secreção de insulina frente à glicose e concentrações despolarizantes de K+ indica que o tratamento com INGAP-PP induziu alterações que tornaram as células ßmais sensíveis a agentes despolarizantes. Quando associamos estes resultados ao aumento da expressão das proteínas formadoras do canal K+ATP e à redução do efluxo de 86Rb pelas ilhotas tratadas com INGAP-PP, podemos sugerir que o aumento no número de canais KATP pode ser um dos responsáveis pelo aumento na secreção de insulina nas ilhotas tratadas com o peptídeo
Abstract: Cultured adult rat islets were used to study the effect of INGAP-PP upon: a) gene expression of Kir6.2 and SUR1 of K+ATP channels and of their transcription factor Foxa2 (RT-PCR), b) protein levels (Western blotting) of SUR1 and Foxa2, c) static and dynamic insulin secretion elicited by metabolic and non metabolic stimuli and d) 86Rb efflux from perifused islets. INGAP-PP increased significantly the expression of Kir6.2, SUR1 and Foxa2 and the protein levels of SUR1 and Foxa2. Islets cultured with INGAPPP and further incubated for 1 h with 2.8 mM glucose, significantly enhanced the release of insulin in response to 40 mM KCl, and 100 µM tolbutamide. The dose-response curve of insulin secretion to increasing glucose concentrations (2.8 to 22.2 mM) shifted to the left in INGAP-PP-cultured islets with an EC50 of 10.0 ± 0.4 vs. 13.7 ± 1.5 mM glucose of the controls (P < 0,05). In dynamic studies INGAP-PP increased significantly the first-phase of insulin secretion elicited by either 22.2 mM glucose or 100 µM tolbutamide and promotes a higher glucose-induced reduction of 86Rb efflux from perifused islets. These results confirm the enhancing effect of INGAP-PP upon insulin release induced by different secretagogues and provide new evidence that such effect is due, at least partly, to an enhanced expression of the SUR1 and Kir6.2 genes of K+ATP channels and of the Foxa2 gene that controls their expression. They would also suggest that INGAP-PP could potentially be used to maintain the capacity of cultured islets to release insulin in response to glucose and maybe for the treatment of diabetes
Mestrado
Fisiologia
Mestre em Biologia Funcional e Molecular
Stoppiglia, Luiz Fabrizio. "Modulação dos mecanismo de defesa das ilhotas pancreaticas contra o estresse oxidativo." [s.n.], 2006. http://repositorio.unicamp.br/jspui/handle/REPOSIP/313936.
Full textTese (doutorado) - Universidade Estadual de Campinas, Instituto de Biologia
Made available in DSpace on 2018-08-06T10:55:45Z (GMT). No. of bitstreams: 1 Stoppiglia_LuizFabrizio_D.pdf: 2405428 bytes, checksum: 6387a533bea2ca65f3826092e2220b39 (MD5) Previous issue date: 2006
Resumo: No diabetes mellitus, radicais de oxigênio estão associados com perda de sensibilidade à glicose ou destruição das células b. Nesse trabalho, investigamos a tolerância de ilhotas de Langerhans de ratos neonatos ao estresse provocado por H2O2, seus mecanismos antioxidantes de defesa e os fatores que promovem manutenção da sensibilidade à glicose. Cultivadas com 1 mM de H2O2, as ilhotas aumentaram até 6' seu consumo de glicose e resistiram ao estresse induzido por H2O2 quando em meio contendo 20 mM de glicose. A expressão da enzima catalase em resposta à glicose se mostrou necessária a essa resistência, mas não suficiente. Em concentrações baixas de H2O2, quando a catalase tem sua atividade modulada por NADPH, observamos que mesmo proteínas sem atividade catalítica adquiriam capacidade antioxidante e eram regeneradas por NADPH. Mapeando a distribuição de atividade peroxidase na ilhota, observamos sensibilidade ao NADPH nas frações nuclear e citossólica. As ilhotas cultivadas em 20 mM de glicose e as que resistem ao H2O2 possuem em comum uma maior atividade da via das pentoses, que gera NADPH citossólico. Nessas ilhotas, verificamos que a produção citossólica de NAD(P)H limita a secreção de insulina. Tais ilhotas produzem NAD(P)H principalmente da oxidação de substratos endógenos no citossol e nas mitocôndrias, ao invés de localizarem seu uso somente no citossol, como se dá nas ilhotas mais sensíveis ao H2O2. A cultura com 20 mM de glicose produziu ilhotas com alta expressão da lançadeira de NADH glicerol-fosfato, enquanto o H2O2 selecionou ilhotas com alta expressão da lançadeira mal/asp. Como ambas as lançadeiras promovem a comunicação entre citossol e mitocôndrias, concluímos que o sistema de lançadeiras e a geração de NADPH sejam fatores críticos para a manutenção da sensibilidade à glicose nas ilhotas
Abstract: In diabetes mellitus, oxygen radicals are associated with loss of glucose-sensibility and destruction of b-cells. In this work, we investigated the tolerance of neonatal rat islets to stress induced by H2O2, the islets antioxidant defense mechanism and factors maintaining islet glucoseresponsiveness. Islets cultured with 1 mM of H2O2 increased 6 fold the glucose uptake and resisted H2O2-induced stress when cultured in media containing 20 mM of glucose. Glucose-induced catalase expression was shown to be necessary to islet cell-survival, although not sufficient. In low H2O2 concentrations, the activity of catalase is dependent on NADPH and we observed that even proteins with no catalytic activity could be antioxidants regenerated by NADPH. Mapping the peroxidase activity in islets, we observed sensibility to NADPH in nuclear and cytossolic fractions. Islets cultured with 20 mM of glucose and islets that survived after culture with H2O2 both showed increased activity of the pentose phosphate pathway, which generate cytossolic NADPH. Is theses islets, we verified that cytossolic production of NAD(P)H limits insulin secretion. Such islets generate NAD(P)H principally from oxidation of endogenous fuels in cytossol and mitochondria, in contrary of the most H2O2-sensible islets which use endogenous fuels exclusively in cytossol. Culture with 20 mM of glucose produced islets with high expression of the glycerol-phosphate NADH shuttle, where as culture with H2O2 selected islets with high expression of the mal/asp shuttle. Since both shuttles promote interchange between cytossol and mitochondria, we have concluded that the shuttle system together with NAD(P)H generation ability are critical factors in maintaining islet glucoseresponsiveness
Doutorado
Fisiologia
Doutor em Biologia Funcional e Molecular
Giozzet, Vanessa Aparecida Gonçalves. "Analise das ações da dexametasona sobre a secreção de insulina, parametros bioquimicos e moleculares em ratos submetidos a restrição proteica." [s.n.], 2008. http://repositorio.unicamp.br/jspui/handle/REPOSIP/314400.
Full textTese (doutorado) - Universidade Estadual de Campinas, Instituto de Biologia
Made available in DSpace on 2018-08-10T23:23:58Z (GMT). No. of bitstreams: 1 Giozzet_VanessaAparecidaGoncalves_D.pdf: 2125921 bytes, checksum: 5e1d4923fcc0268442cc60af14fa58dd (MD5) Previous issue date: 2008
Resumo: A desnutrição e a resistência periférica à insulina induzida por administração de glicocorticóides induzem compensações funcionais e morfológicas em ilhotas pan creáticas a fim de manter a homeostase glicêmica. Deste modo, investigamos as alterações desenvolvidas pelo tratamento com dexametasona (Dex) em animais submetidos à restrição protéica. Foram analisados: parâmetros metabólicos, secreção de insulina em resp osta a glicose e proteínas envolvidas na via de sinalização da insulina em ilhotas pancreáticas isoladas. Ratos submetidos à dieta hipoprotéica (LP) apresentaram características padrões que caracterizam a desnutrição como: diminuição de ganho de massa corp oral, redução dos níveis séricos de albumina, proteína total e insulina. Adicionalmente, os ratos LP exibiram aumento da sensibilidade periférica à insulina e redução da área das ilhotas pancreáticas comparadas ao grupo controle ( P < 0,05). Todos estes parâmetros apresentaram valores similares ao grupo controle nos ratos submetidos à dieta hipoprotéica e submetidos ao tratamento com Dex (LPD), exceto para o peso corpóreo ( P < 0,05). A secreção de insulina em ilhotas pancreáticas isoladas de ratos LPD aprese ntou maior responsividade à glicose, em níveis estimulatórios, comparados a secreção em ilhotas de ratos LP (P < 0,05). Paralelo aos resultados de secreção, os ratos LPD exibiram redução do conteúdo protéico de IRS-1, IRS-2 e aumento dos níveis protéicos d e p-FoxO1, p-ERK e PKC comparados ao grupo LP (P < 0,05). Concomitantemente, as ilhotas dos ratos LPD mostraram ¿se hipertrofiadas comparadas com ilhotas de ratos LP ( P < 0,05). Em conclusão, o tratamento com dexametasona reverte, ao menos parcialmente, os efeitos no metabolismo analisados e no funcionamento das ilhotas pancreáticas causados pela restrição protéica, confirmando a grande plasticidade das células ß frente a condições adversas facultativas e/ou permanentes
Abstract: Malnutrition caused by protein restriction and dexamethasone -induced insulin resistance, in vivo treatment (Dex) are conditions associated with morphological and functional alterations in pancreatic islets. Thus, the present study evaluated the dexamethasone treatment effects on the metabolic parameters, glucose-stimulated insulin secretion and proteins involved in the insulin - signalling pathway over low protein diet fed rats (LP). LP rats showed decrease in body weight, serum insulin, total serum protein, and serum albumin, patte rns that characterize the LP rats. Moreover, LP rats presented improved peripheral insulin sensibility and reduced islets area (P < 0,05). Except for the body weight (P < 0,05), all these parameters were proned to be normalized in rats exposed to a low protein diet and treated with dexamethasone (LPD), whose islets showed increased glucose stimulated insulin secretion (GSIS). In addition, LPD rats showed lower protein expression of IRS-1, IRS-2 and higher in p-FoxO1, p-ERK and PKC, while presenting pancreatic islet hypertrophy compared to LP rats islet. In conclusion, dexamethasone treatment revert the effects related to metabolism and islet function caused by diet protein restriction, confirming ß-cells wide plasticity, even in transient or lasting adverse conditions
Doutorado
Fisiologia
Doutor em Biologia Funcional e Molecular
Barthson, Jenny. "Transcription factors and downstream genes modulating TNF-gas + IFN-gcs induced beta cell apoptosis." Doctoral thesis, Universite Libre de Bruxelles, 2013. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/209491.
Full textTNF-α+IFN-γ induces beta cell apoptosis through the intrinsic pathway of cell death. This involved activation of the BH3 only proteins DP5, PUMA and Bim. Knockdown (KD) of either DP5 or PUMA or both led to a partial protection of INS-1E cells (12-20%), while silencing Bim led to about 60% protection against cytokine-induced apoptosis. Bim is transcriptionally induced by activated STAT1. TNF-α+IFN-γ also induces downregulation of Bcl-XL, an anti-apoptotic Bcl-2 gene which inhibits Bim. Knocking down Bcl-XL alone led to increase in apoptosis, but this was prevented by the parallel KD of Bim.
The ultimate goal of our research is to protect beta cells from the autoimmune assault. Previous data revealed that JunB inhibits ER stress and apoptosis in beta cells treated with IL-β+IFN-γ. Here, TNF-α+IFN-γ up-regulated the expression of JunB which was downstream of activated NF-ĸB. JunB KD exacerbated TNF-α+IFN-γ induced beta cell death in primary rat beta cells and INS-1E cells. The gene networks affected by JunB were studied by microarray analysis. JunB regulates 20-25% of the cytokine-modified beta cell genes, including the transcription factor ATF3 and Bcl-XL. ATF3 expression was increased in cytokine-treated human islets and in vitro silencing of JunB led to >60% reduction in ATF3 overexpression. We confirmed direct JunB regulation of the ATF3 promoter by its binding to an ATF/CRE site. Silencing of ATF3 aggravated TNF-α+IFN-γ induced cell death in beta cells and led to the downregulation of Bcl-XL expression in INS-1E cells. Pharmacological upregulation of JunB using forskolin led to upregulation of ATF3 and consistent protection of these cells against cytokine-induced cell death, while genetic overexpression of JunB in mice increased ATF3 expression in the pancreatic islets and reversed the pro-apoptotic effects of cytokines on beta cells (±40 % protection).
As a whole, our findings indicate that TNF-α+IFN-γ triggers beta cell apoptosis by the upregulation of the pro-apoptotic protein Bim and downregulation of the Bcl-XL protein. These deleterious effects are at least in part antagonized by JunB via activation of ATF3.
Dans le diabète de type 1 (DT1), la combinaison de facteurs génétiques de prédisposition et de l'environnement déclenche l'inflammation des îlots de Langerhans (insulite) conduisant à une destruction sélective et progressive des cellules bêta du pancréas. Les cellules bêta meurent principalement d’apoptose, déclenchée au moins en partie par les cytokines pro-inflammatoires sécrétées par les cellules immunitaires comme l’IL-β, le TNF-α l’IFN-γ. De récentes découvertes suggèrent que la voie mitochondriale de la mort cellulaire jouerait un rôle dans la mort de ces cellules. L'analyse de réseaux de gène utilisant les biopuces d’ADN indique que l’association TNF-α+IFN-γ induit l’activation de facteurs de transcription tels que NF-ĸB, STAT1 et AP-1 dans la cellule bêta. Dans ce contexte, nous avons cherché à examiner les voies de l'apoptose déclenchées par le TNF-α+IFN-γ dans la cellule bêta.
En présence de TNF-α+IFN-γ les cellules bêta meurent par apoptose via la voie intrinsèque. L’activation des protéines pro-apoptotiques « BH3-seulement » dont DP5, PUMA et Bim étaient en cause de cette apoptose. Le « knockdown »1 (KD), de DP5 ou de PUMA, ou des deux en même temps conduit à une protection partielle des cellules INS-1E (12-20%), tandis que le KD de Bim conduit à environ 60% de protection contre l’apoptose induite par cette combinaison de cytokines. La transcription de Bim est induite par STAT1 activé. Parallèlement à la régulation positive de Bim, TNF-α+IFN-γ conduit à la régulation négative de la protéine Bcl-XL. Bcl-XL est une protèine anti-apoptotique de la famille de protèines Bcl-2 qui en general inhibe Bim. Réduire l’expression de Bcl-XL seul induit une augmention de l'apoptose, alors que le KD de Bim et Bcl-XL en parallèle empêche l'apoptose.
Le but ultime de notre recherche est de protéger les cellules bêta des agressions autoimmunitaires. Les données antérieures ont révélé que JunB inhibe le stress du réticulum endoplasmique et l'apoptose dans les cellules bêta traitées avec IL-β+IFN-γ. Nous avons observé que TNF-α+IFN-γ induit l'expression de JunB qui se produit en aval de NF-ĸB activé. Il est important de noter que l’inactivation de JunB par des agents interférants de l’ARN (siRNA) exacerbe la mort des cellules primaires bêta de rat et de cellules INS-1E induite par les cytokines. Les réseaux de gènes touchés par JunB ont été étudiés grâce a l'analyse en microréseaux. JunB règule 20-25% des gènes modifiés par des cytokines dans les cellules bêta, y compris le facteur de transcription ATF3 et Bcl-XL. L’expression d’ATF3 est augmenté dans les îlots humains traités avec les cytokines et la répression in vitro de JunB conduit à une réduction de >60% de l’expression d’ATF3. Nous avons confirmé la régulation d’ATF3 par JunB en montrant que JunB est directement lié au promoteur d’ATF3 via le site ATF/CRE. La diminution d’expression d’ATF3 en presence de TNF-α+IFN-γ a aggravé la mort cellulaire induite dans les cellules bêta et a conduit à la régulation négative de l'expression de Bcl-XL dans les cellules INS-1E. L’augmentation pharmacologique de JunB dans les cellules INS-1E par l’utilisation de forskolin a conduit à la régulation positive en aval d’ATF3 et par conséquente à la protection de cellules bêta vis-a-vis de effets indésirables des cytokines. Dans cette optique, la surexpression génétique de JunB dans le modèle Ubi-JunB de souris transgénique a conduit à une surexpression d’ATF3 dans les îlots pancréatiques et a permir d’inverser les effets pro-apoptotiques de cytokines sur la cellule bêta (protection ± 40%).
Globalement, ces résultats indiquent que TNF-α+IFN-γ déclenche l'apoptose des cellules bêta par la régulation positive du gène pro-apoptotique Bim et la régulation négative du gène anti-apoptotique Bcl-XL. Ces effets indésirables sont inhibé en partie par JunB via l’activation de ATF3.
1Pas d’équivalent en français. Signifie la réduction de l’expression d’un gène via utilisation d’un siRNA (agent interférant de l’ARN).
Doctorat en Sciences biomédicales et pharmaceutiques
info:eu-repo/semantics/nonPublished
Gregg, Randal K. "Mechanisms underlying diabetogenesis in the NOD mouse." Free to MU campus, others may purchase, 2003. http://wwwlib.umi.com/cr/mo/fullcit?p3115548.
Full textBatista, Thiago Martins 1984. "Modulação do mecanismo de sedreção de insulina em ilhotas pancreaticas de ratos submetidos a restrição protetica e suplementados com taurina." [s.n.], 2009. http://repositorio.unicamp.br/jspui/handle/REPOSIP/314196.
Full textDissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia
Made available in DSpace on 2018-08-13T21:03:55Z (GMT). No. of bitstreams: 1 Batista_ThiagoMartins_M.pdf: 1168177 bytes, checksum: 6c327ab4c396fab9844364b47f69ad79 (MD5) Previous issue date: 2009
Resumo: A desnutrição ainda é um problema de saúde pública que afeta principalmente países em desenvolvimento e sua prevalência chega a ser crescente em algumas áreas. Vários estudos obtiveram êxito em correlacionar a má nutrição em estágios iniciais de vida com o desenvolvimento de doenças cardiovasculares e diabetes tipo 2 na vida adulta. No modelo de desnutrição pós desmame verifica-se menor secreção de insulina estimulada por glicose e outros agentes insulinotrópicos bem como menor expressão de várias proteínas envolvidas com a funcionalidade da célula b. Estudos realizados por nosso grupo e outros laboratórios mostram que a suplementação de camundongos com taurina aumenta a secreção de insulina além de regular o influxo de íons Ca2+ para as células b, etapa crucial para o processo secretório. Para avaliar os efeitos da taurina sobre animais desnutridos, utilizamos ratos wistar, machos com 21 dias de vida. Os animais receberam dieta contendo 17% de proteína (normoprotéica) (C) ou 6% de proteína (hipoprotéica) (D). Animais C e D receberam suplementação com taurina a 2,5% na água de beber por 30 dias (CT30 e DT30) ou 90 dias (CT90 e DT90). Em seguida avaliamos parâmetros biométricos e bioquímicos, tolerância à glicose, secreção de insulina estimulada por glicose e pelo agonista colinérgico carbacol, expressão de proteínas envolvidas no controle da secreção de insulina e, finalmente, registramos os movimentos citoplasmáticos de íons Ca2+ após estímulo com glicose e carbacol. Verificamos que a restrição protéica retardou o crescimento dos animais além de reduzir a concentração plasmática de proteínas totais (C = 6,81±0,04; CT30 = 7,15±0,54; CT90 = 6,87±0,19; D = 5,35±0,24; DT30 = 5,37±0,28; DT90 = 5,70±0,09 g/dl; n = 3-5) e albumina (C = 3,20±0,11; CT30 = 3,41±0,02; CT90 = 3,18±0,05; D = 2,74±0,07; DT30 = 2,49±0,09; DT90 = 2,67±0,04 g/dl; n = 5-9) sem efeito da suplementação com taurina. Os animais D se mostraram mais tolerantes à glicose e a suplementação com taurina por 90 dias restaurou parcialmente a tolerância desses animais (C = 30249±2682; CT30 = 37255±6691; CT90 = 29365±2257; D = 16916±1609; DT30 = 18791±2859; DT90 = 23425±3856 AAC; n = 5-9). Nesse trabalho mostramos que a suplementação com taurina corrige a hipoinsulinemia verificada em animais desnutridos alimentados (C = 4,97±0,34; CT90 = 3,56±0,52; D = 1,39±0,10; DT90 = 3,31±0,70 ng/ml; n = 5-8) bem como a responsividade de ilhotas isoladas a concentrações crescentes de glicose. Verificamos também que a taurina normaliza a secreção de insulina potencializada pelo carbacol (C = 9,4+0,8; CT90 = 12,4+0,7; D = 6,4+0,5; DT90 = 9+0,7 ng/ml; n = 12). As respostas secretórias foram observadas em conjunto com a regulação da expressão das proteínas SERCA3 (C = 100+21; CT90 = 174+17; D =96+90; DT90 = 149+11 % do C; n = 6), receptor muscarínico M3 (C = 100+24; CT90 = 155+80; D = 51+10; DT90 = 108+14 % do C; n = 5) e sintaxina 1 (C = 100+30; CT90 = 92+40; D = 50+12; DT90 = 77+11 % do C; n = 5) que participam do controle de diferentes etapas do processo de secreção de insulina. Por fim, verificamos que a suplementação com taurina melhorou o padrão de oscilação de íons Ca2+ após estímulo com glicose. Concluímos então que a suplementação com taurina por 90 dias restaura a sensibilidade das ilhotas à glicose e ao carbacol possivelmente pela regulação do fluxo de cálcio para as células b bem como pela modulação da expressão de proteínas que controlam o processo de secreção de insulina.
Abstract: Malnutrition still is a public health issue, especially in developing countries. Many studies correlate malnourishment during early life and the development of cardiovascular disease and type 2 Diabetes Mellitus on latter stages. Animal models of malnutrition reveal impaired insulin secretion stimulated by glucose and other insulinotropic agents as well as lower expression of key proteins for b cell function. The literature shows that taurine supplementation increases insulin secretion and regulates calcium dynamics on b cells. Male, 21 days old, wistar rats received diet containing 17% (C) or 6% (D) of protein. Both groups received taurine supplementation on the drinking water for 30 (CT 30 and DT 30) and 90 (CT90 and DT 30) days. Next we assessed biometric and biochemical parameters, glucose tolerance, glucose and carbacholstimulated insulin secretion, protein expression of muscarinic M3 receptor, Phospholipase C b2, SERCA3, Syntaxin 1 and, finally, we registered cytoplasmic Ca2+ after stimulus with glucose and carbachol. Protein restricted rats showed lower body weight, plasma proteins (C = 6,81±0,04; CT30 = 7,15±0,54; CT90 = 6,87±0,19; D = 5,35±0,24; DT30 = 5,37±0,28; DT90 = 5,70±0,09 g/dl; n = 3-5), albumin (C = 3,20±0,11; CT30 = 3,41±0,02; CT90 = 3,18±0,05; D = 2,74±0,07; DT30 = 2,49±0,09; DT90 = 2,67±0,04 g/dl; n = 5-9) and increased glucose tolerance (C = 30249±2682; CT30 = 37255±6691; CT90 = 29365±2257; D = 16916±1609; DT30 = 18791±2859; DT90 = 23425±3856 AUC; n = 5-9). Taurine supplementation had no effect upon nutritional status parameters and partially restored glucose tolerance and insulinemia to C levels. Taurine increased secretory response to glucose and carbachol (C = 9,4+0,8; CT90 = 12,4+0,7; D = 6,4+0,5; DT90 = 9+0,7 ng/ml; n = 12). It also increased protein expression of M3 receptor (C = 100+24; CT90 = 155+80; D = 51+10; DT90 = 108+14 % of C; n = 5), SERCA 3 (C = 100+21; CT90 = 174+17; D =96+90; DT90 = 149+11 % of C; n = 6) and syntaxin 1 (C = 100+30; CT90 = 92+40; D = 50+12; DT90 = 77+11 % of C; n = 5). Finally, taurine supplementation for 90 days improved Ca2+ dynamics when the islets were stimulated with glucose. In conclusion, these data show that taurine supplementation restores secretory responsiveness to glucose and carbachol possibly through Ca2+ dynamics modulation and increased expression of key proteins for insulin secretion.
Mestrado
Fisiologia
Mestre em Biologia Funcional e Molecular
Vanzela, Emerielle Cristine 1982. "Dieta de cafeteria induz obesidade, resistência periférica a insulina, e reduz a secreção deste hormônio por ilhotas de ratas = restauração do processo secretório, mas não da sensibilidade à insulina durante a prenhez." [s.n.], 2010. http://repositorio.unicamp.br/jspui/handle/REPOSIP/313918.
Full textTese (doutorado) - Universidade Estadual de Campinas, Instituto de Biologia
Made available in DSpace on 2018-08-16T00:11:07Z (GMT). No. of bitstreams: 1 Vanzela_EmerielleCristine_D.pdf: 2535043 bytes, checksum: eee7b54cea5f470c5637de8c4b3385f5 (MD5) Previous issue date: 2010
Resumo: A obesidade atingiu proporções alarmantes constituindo-se num fator de risco para o desenvolvimento de várias doenças. O aumento da resistência periférica à insulina acompanha esta patologia e a incapacidade da célula beta pancreática em suprir a maior necessidade por insulina leva ao desenvolvimento de intolerância à glicose, hiperglicemia e diabetes. Por esta razão, é importante investigar mecanismos que tornem a célula beta capaz de aumentar sua capacidade secretória. A exemplo da obesidade, resistência periférica à insulina é também observada durante a prenhez. No entanto, neste caso, a célula beta é capaz de aumentar a produção e secreção do hormônio, mantendo a tolerância à glicose em condições adequadas. Diante disso,decidimos investigar a sensibilidade à insulina e a consequente resposta das células beta pancreáticas durante a prenhez em ratas obesas. Observamos que a alimentação com a dieta de cafeteria aumentou o ganho de peso, bem como os depósitos de gordura das ratas. Ratas obesas não-prenhes (Caf) e prenhes (CafP) apresentaram tolerância à glicose diminuída, associada a um aumento da insulina plasmática em resposta à sobrecarga de glicose no grupo CafP. Apesar disso, as glicemias de jejum e pós-prandial foram normais nos dois grupos. No entanto, as ratas Caf e CafP apresentaram hiperinsulinemia (jejum e alimentado), aumento do índice insulina/glicose e do AGL plasmático (alimentado). Ainda, houve redução na sinalização da insulina no fígado e músculo esquelético das ratas Caf e CafP, aos 15 e aos 19 dias de prenhez, de forma mais exacerbada do que a redução observada nas ratas controle prenhes. Em paralelo, as ilhotas isoladas das ratas Caf secretaram menos insulina em resposta a diferentes estímulos. Contudo, o conteúdo total de insulina, a secreção estimulada por PMA (ativador da PKC), a produção decompostos redutores e a oxidação de glicose, na presença de 11,1 mmol/L do açúcar, foram similares entre as ratas Caf e as controle não-prenhes. Entretanto, as ilhotas isoladas das ratas Caf apresentaram redução na mobilização do Ca2+ citoplasmático livre frente à glicose ou tolbutamida, acompanhada pela redução da expressão gênica da subunidade ?1.2 do canal de cálcio voltagem-dependente (CaVa1.2), e da Ca2+- ATPase do retículo endoplasmático tipo 2a. Independente da dieta, a prenhez aumentou a secreção de insulina em resposta à glicose, a produção de compostos redutores, a oxidação de glicose, a amplitude e a frequência das oscilações do Ca2+ citoplasmático e, a expressão gênica do CaVa1.2. Concluindo, a prenhez nas ratas obesas melhorou o manejo do Ca2+ e restaurou a secreção de insulina por ilhotas isoladas. Contudo, esta restauração não foi suficiente para vencer o aumento da resistência periférica à insulina e normalizar a tolerância à glicose nas ratas obesas
Abstract: The incidence of obesity reached alarming levels worldwide. This illness constitutes a risk factor for the development of several other diseases. The augmented peripheral insulin resistance accompanies this pathology, and the failure of the pancreatic beta cell to overcome the higher demand for insulin causes glucose intolerance, hyperglycemia and diabetes. For this reason, it became interesting to investigate mechanisms that make the beta cell capable to increases its secretory capacity. As obesity, peripheral insulin resistance is also observed during pregnancy. Nevertheless, in this situation, the beta cell is capable to enhance insulin production and release, maintaining glucose tolerance at adequate levels. Therefore, we decided to investigate insulin sensibility and the consequent beta cell response during pregnancy in obese rats. We observed that cafeteria diet enhanced weight gain and fat pads in rats. Despite no differences were noticed in obese non-pregnant (Caf) and pregnant (CafP) rats, during fast and fed states, the glucose tolerance was diminished in these rats, associated with an augmented plasma insulin levels in response to a glucose load inCafP rats. However, Caf and CafP rats had hyperinsulemia (fast and fed), higher insulin/glucose index, and enhanced plasma FFA (fed state). In addition, we observed a reduction in insulin signaling in liver and skeletal muscle from Caf and CafP rats, at15th and 19th days of pregnancy, higher than that registered in control pregnant rats. Also, there was a reduction in insulin secretion induced by different stimuli in is lets from Caf rats. However, total islet insulin content, PMA-stimulated insulin secretion, production of reducing equivalents, and glucose oxidation in the presence of 11.1mmol/L glucose, were similar between islets from Caf and non-pregnant control rats .Nevertheless, glucose- and tolbutamide-induced Ca2+ mobilization, a1.2 subunit of thevoltage sensitive Ca2+ channel (CaVa1.2), and sarcoendoplasmic reticulum Ca2+ATPase 2a gene expression were reduced in islets from Caf rats. Independently of the diet, pregnancy enhanced glucose stimulated insulin secretion, reducing equivalents production, glucose oxidation, amplitude and frequency of cytoplasm Ca2+ oscillations, and CaVa1.2 gene expression. In conclusion, although pregnancy improved Ca2+ handling and restored insulin secretion in cafeteria diet-induced obese rats, this restoration was not enough to overcome the increase in peripheral resistance and normalize glucose tolerance in these obese rats
Doutorado
Fisiologia
Doutor em Biologia Funcional e Molecular
Purificação, Thais Almeida 1980. "Participação das proteínas AS160 e Rab27A na secreção de insulina de ratos controles e insulino-resistentes por dexametasona." [s.n.], 2012. http://repositorio.unicamp.br/jspui/handle/REPOSIP/313950.
Full textDissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia
Made available in DSpace on 2018-08-20T10:53:44Z (GMT). No. of bitstreams: 1 Purificacao_ThaisAlmeida_M.pdf: 1255549 bytes, checksum: 5142cacf6ca932aa0dd1a86b9eef5074 (MD5) Previous issue date: 2012
Resumo: Administração de glicocorticóides em roedores e humanos aumenta a resistência à insulina (RI). A RI, provocada por dexametasona, leva a hiperinsulinemia por aumento da secreção do hormônio pelas ilhotas pancreáticas. Recentemente, demonstrou-se que a AS160, uma GAP (proteína ativadora de GTPase), participa no tráfego de vesículas em diferentes tipos celulares que, por sua vez, pode ser alterado por dexametasona. Neste trabalho, avaliamos possível participação da AS160 na secreção de insulina em ilhotas de ratos RI por dexametasona, para isto foram avaliadas proteínas envolvidas no processo de secreção; pAS160, Akt e AMPK. Ratos Wistar adultos foram tratados com o glicocorticóide (DEX) com 1mg/kg (ip) de peso corporal, ou salina (CTL), durante 5 dias. Ao final do período de tratamento, os ratos foram submetidos a um Teste de Tolerância à Glicose intraperitoneal (ipGTT) e, após sacrifício, amostras de sangue foram coletadas para dosagem de insulina. As ilhotas pancreáticas foram isoladas por digestão do pâncreas com colagenase. As proteínas insulares foram avaliadas por Western Blot e os genes por RCP-TR. A insulina, contida nas amostras de sangue e nas incubações de ilhotas, foi medida por radioimunoensaio (RIA). A razão pAS160/AS160 foi aumentada nas ilhotas DEX (P<0,05). Nestas ilhotas, resultados semelhantes foram observados para a razão pAkt/Akt (P<0,05). O tratamento com DEX também aumentou a expressão gênica e protéica da Rab27A (P<0,05), contudo, reduziu significativamente sua associação com a AS160 (P<0,05). A associação entre essas duas proteínas foi observada pela primeira vez nas ilhotas neste trabalho. O tratamento com DEX também reduziu as expressões gênica e protéica bem como a fosforilação da AMPK. A secreção de insulina foi maior nas ilhotas DEX comparado à CTL e, em ambas, a secreção foi diminuída pela wortmanina (inibidor da PI3K). Ilhotas de ratos CTL e DEX, tratados com anti-sense anti-AS160, tiveram o conteúdo protéico da AS160 reduzido em ± 80%, comparado ao CTL (P<0,05). Nas ilhotas de ratos CTL knockdown, a secreção de insulina foi maior que nos CTL e, nas ilhotas dos DEX knockdown a secreção foi semelhante às DEX. Concluindo, o aumento da secreção de insulina em ilhotas de ratos RI por dexametasona envolve a participação da AS160 e, essa potencialização parece ser mediada pela via PI3K/Akt. Esse aumento de secreção parece também ser diretamente proporcional ao aumento da dissociação entre a Rab27A e a AS160
Abstract: It is well known that glucocorticoids induce insulin resistance (IR). It is also known that dexamethasone-induced IR is linked to increased levels of plasma insulin due to higher insulin secretion by pancreatic islets. Recent findings show that the Rab-GTPase AS160 plays a role in the traffic of vesicles in different cells type that, in turn, may be affected by dexamethasone. Here, we evaluated the participation of AS160 in the insulin secretion in islets from dexamethasone treated rats. Adult rats were treated with dexamethasone (DEX) with 1.0 mg/kg, body weight (ip) or saline (CTL) for 5 consecutive days. Insulin resistance was evaluated by intraperitoneal Glucose Tolerance Test (ipGTT). After, the rats were sacrificed and the islets isolated by the digestion of their pancreases with collagenase. Protein was measured by Western- Blot, and insulin by RIA. AS160 expression, phosphorylation, and the pAS160/AS160 ratio were increased in DEX islets (P<0.05). Similar results were observed for Akt (P<0.05). Dexamethasone also increased Rab27a protein and gene expression but significantly reduced its association with AS160. The association between these two proteins was observed in pancreatic islets for the first time in this work. AMPK gene and protein expression as well as phosphorylation were reduced by Dexamethasone (P<0.05). The insulin secretion was higher in DEX compared with CTL islets (P<0.05). Both secretions were reduced by wortmanin. Islets from CTL and DEX rats, treated with anti-sense anti-AS160, showed ± 80% reduction on its expression. The CTL knockdown islets secreted more insulin than CTL and the DEX knockdown secreted similar amount of insulin than DEX islets. In conclusion, these results indicated that AS160 participates in the increased insulin secretion in islets from DEX rats, and this effect seems to be dependent on the activation of the PI3K/Akt pathway. The increase in insulin secretion also depends on the dissociation between Rab27a and AS160
Mestrado
Fisiologia
Mestre em Biologia Funcional e Molecular
Estil·les, Altimiras Elisabet. "Efectes de la sobreexpressió d’IGF2 en la protecció i la regeneració de les cèl·lules beta pancreàtiques." Doctoral thesis, Universitat de Barcelona, 2014. http://hdl.handle.net/10803/285812.
Full textβ-Cell mass reduction has a central role in the development of type 1 and type 2 diabetes, and in both conditions the loss of β-cells has been largely attributed to increased β-cell death. Furthermore several reports have highlighted the fundamental contribution of β-cell replication to the physiological maintenance of β-cell mass, and to β-cell mass regeneration in models with reduced β-cell mass. This may suggest that impaired β-cell replication could contribute to the reduction of β-cell mass in diabetes. Islet transplantation restores normoglycemia in type 1 diabetic patients. However, islet transplantation presents some important limitations. A basic restriction is the low organ availability and high requirement, which is exacerbated by the high islet mass that must be transplanted to achieve normoglycemia, probably due to the massive destruction of islets taking place in the initial days after transplantation due to increased beta-cell apoptosis, necrosi and impaired beta-cell replication. IL-1β is an important contributor to β-cell damage in type 1 diabetes, and recently it has also been related to the development of type 2 diabetes. IL-1beta also could contribute to the dramatic beta cell loss that takes place after islet transplantation IGF2 is a growth promoting peptide which is able to stimulate cell differentiation, proliferation and survival. Thus, IGF2 may play a dual beneficial role on β-cell mass, acting both as a mitogenic and as a survival factor for β-cells. We investigated in vitro and in vivo effects of the IGF2 overexpression on β-cell survival and regeneration. The aim of the in vitro study was to characterise the effect of IL-1β on β-cell replication, and the potential modulation by IGF2. Since the induction of β-cell proliferation by IGFs is dependent on ambient glucose concentration, low and high glucose concentrations were used to better define the effects of IL-1β and IGF2 on β-cell replication. The aim of the in vivo study was to determine the effect of IGF2 overexpression on β-cell mass in transplanted islets. In the in vitro study, control-uninfected and adenovirus encoding for IGF2 (Ad-IGF2)-infected rat islets were cultured at 5.5 or 22.2 mmol/l glucose with or without 1, 10, 30, and 50 U/ml of IL-1β. β-Cell replication was markedly reduced by 10 U/ml of IL-1β and was almost nullified with 30 or 50 U/ml of IL-1β. Higher concentrations of IL-1β were required to increase β-cell apoptosis. Although IGF2 overexpression had a strong mitogenic effect on β-cells, IGF2 could preserve β-cell proliferation only in islets cultured with 10 U/ml IL-1β, and had no effect with 30 and 50 U/ml of IL-1β. In contrast, IGF2 overexpression induced a clear protection against IL-1β-induced apoptosis, and higher concentrations of the cytokine were needed to increase β-cell apoptosis in Ad-IGF2-infected islets. These results indicate that β-cell replication is highly sensitive to the deleterious effects of the IL-1β as shown by the inhibition of replication by relatively low IL-1β concentrations, and the almost complete suppression of β-cell replication with high IL-1β concentrations. Likewise, the inhibitory effects of IL-β on β-cell replication were not modified by glucose, and were only modestly prevented by IGF2 overexpression, in contrast with the higher protection against IL-1β-induced apoptosis afforded by glucose and by IGF2 overexpression. In the in vivo study, islets infected with adenovirus encoding for IGF2 (Ad-IGF2 group), for luciferase (Ad-Luc control group), or with uninfected islets (control group) were syngeneically transplanted to streptozotocin-diabetic Lewis rats. Eight hundred islets, a minimal mass model to restore normoglycemia, or 500 islets, a clearly insufficient mass, were transplanted. Rats transplanted with 800 Ad-IGF2 islets showed a better metabolic evolution than control groups. As expected, rats transplanted with 500 Ad-IGF2 or control islets maintained similar hyperglycemia throughout the study, ensuring comparable metabolic conditions among both groups. β-Cell replication was higher in Ad-IGF2 group than in control group on days 3, 10, and 28 after transplantation. β-Cell mass was similarly reduced on day 3 after transplantation in Ad-IGF2 and control group, it increased on day 10, and on day 28 it was higher in Ad-IGF2 than in control group. Apoptosis was similarly increased in Ad-IGF2 and control islets after transplantation. No differences in insulin secretion were found between Ad-IGF2 and uninfected control islets. In summary, IGF2 overexpression in transplanted islets increased β-cell replication, induced the regeneration of the transplanted β-cell mass, and had a beneficial effect on the metabolic outcome reducing the β-cell mass needed to achieve normoglycemia. Taken together, these results suggest that strategies aimed to preserve or increase the engrafted β-cell mass may be useful for inducing the regeneration of beta mass for the treatment of diabetes and in islet transplantation.
Violato, Natalia Moretti [UNESP]. "Avaliação do estado inflamatório em ilhotas de Langerhans de camundongos portadores do tumor sólido de Ehrlich." Universidade Estadual Paulista (UNESP), 2013. http://hdl.handle.net/11449/87801.
Full textA manutenção da homeostase energética é, sem duvida, o aspecto fisiológico mais importante para a garantia de sobrevivência animal. Doenças crônicas como câncer são capazes de alterar esta homeostase, agravada principalmente pela presença do tumor. O conjunto de sintomas envolvidos neste quadro de desequilíbrio metabólico, comum a diversas doenças, foi agrupado e caracterizado como uma síndrome metabólica denominada caquexia que, entre outros fatores, leva à progressiva perda de peso, perda de tecido muscular e adiposo, e está frequentemente associado a sintomas de anorexia e inflamação sistêmica. Na caquexia induzida por câncer, o desequilíbrio no metabolismo de carboidratos é um sintoma frequente, especialmente alterações no perfil secretório de insulina. Da mesma forma, a presença tumoral gera um estado de inflamação sistêmica que há algum tempo tem sido apontada como principal responsável pela alteração funcional de diversos órgãos, acarretando na progressão da síndrome. No entanto, não há trabalhos na literatura que correlacionem o papel da inflamação sistêmica gerada pelo desenvolvimento tumoral com a alteração no metabolismo de carboidratos, principalmente aquelas relacionadas à secreção de insulina. Em resultados anteriores evidenciamos que camundongos portadores do tumor sólido de Ehrlich (TSE) exibiram drástica diminuição na capacidade secretória de insulina, hipoinsulinemia, maiores sensibilidade a este hormônio e tolerância à glicose. Deste trabalho, inúmeras possibilidades de estudo surgiram, dentre elas a investigação do quadro inflamatório na ilhota como possível causador das alterações na secreção de insulina. Diante da escassez de trabalhos nesta área e diante da importância da adequada secreção de insulina e da homeostase glicêmica na melhora da sobrevida de portadores de doenças malignas, foi proposta do presente estudo avaliar...
The maintenance of energy homeostasis is one of the most crucial physiological tasks to ensure long-term survival in animals. Chronic diseases, as cancer, are capable to lead to homeostasis imbalance mainly by tumor presence and the cluster of symptoms involved in this process was named cachexia. Cancer cachexia is a metabolic syndrome characterized by a marked weight loss, loss of muscle and adipose tissues and is frequently associated with anorexia and systemic inflammation. Alterations in carbohydrate metabolism are frequent in cancer cachexia, especially insulinemic alterations. In the same way, tumor presence promotes severe systemic inflammation in the host, and it was demonstrated that this is responsible for functional alterations in many organs leading to cachexia progression. However, there are no studies that correlate the role of systemic inflammation with the alterations in carbohydrate metabolism, mainly related with alterations in insulin secretion. In previous studies we demonstrated that solid Ehrlich carcinoma-bearing mice (SET) showed drastic decrease in insulin secretion, hipoinsulinemia, increase in insulin sensitivity and glucose tolerance. With these results, numerous opportunities for study appeared, among then the establishment of inflammatory response in islets. Considering the lack of studies in this area and considering the importance of proper insulin secretion and glicemic homeostasis to the survival of cancer patients, we evaluated inflammatory response components in pancreatic islets of solid Ehrlich tumor-bearing mice in order to seek consistent information about possible mechanisms involved in alterations in insulin secretion in SET group. For this, pancreatic islets of control (CTL) and SET bearing mice were analyzed 14 days after tumor inoculation for determination of the expression of the proinflammatory citokynes TNF-α, IL-1β, IFNγ, IFN-α, IL-6 e IL-8, and ...
Violato, Natalia Moretti. "Avaliação do estado inflamatório em ilhotas de Langerhans de camundongos portadores do tumor sólido de Ehrlich /." Botucatu, 2013. http://hdl.handle.net/11449/87801.
Full textBanca: José Maurício Sforcin
Banca: Silvana Bordin
Resumo: A manutenção da homeostase energética é, sem duvida, o aspecto fisiológico mais importante para a garantia de sobrevivência animal. Doenças crônicas como câncer são capazes de alterar esta homeostase, agravada principalmente pela presença do tumor. O conjunto de sintomas envolvidos neste quadro de desequilíbrio metabólico, comum a diversas doenças, foi agrupado e caracterizado como uma síndrome metabólica denominada caquexia que, entre outros fatores, leva à progressiva perda de peso, perda de tecido muscular e adiposo, e está frequentemente associado a sintomas de anorexia e inflamação sistêmica. Na caquexia induzida por câncer, o desequilíbrio no metabolismo de carboidratos é um sintoma frequente, especialmente alterações no perfil secretório de insulina. Da mesma forma, a presença tumoral gera um estado de inflamação sistêmica que há algum tempo tem sido apontada como principal responsável pela alteração funcional de diversos órgãos, acarretando na progressão da síndrome. No entanto, não há trabalhos na literatura que correlacionem o papel da inflamação sistêmica gerada pelo desenvolvimento tumoral com a alteração no metabolismo de carboidratos, principalmente aquelas relacionadas à secreção de insulina. Em resultados anteriores evidenciamos que camundongos portadores do tumor sólido de Ehrlich (TSE) exibiram drástica diminuição na capacidade secretória de insulina, hipoinsulinemia, maiores sensibilidade a este hormônio e tolerância à glicose. Deste trabalho, inúmeras possibilidades de estudo surgiram, dentre elas a investigação do quadro inflamatório na ilhota como possível causador das alterações na secreção de insulina. Diante da escassez de trabalhos nesta área e diante da importância da adequada secreção de insulina e da homeostase glicêmica na melhora da sobrevida de portadores de doenças malignas, foi proposta do presente estudo avaliar ...
Abstract: The maintenance of energy homeostasis is one of the most crucial physiological tasks to ensure long-term survival in animals. Chronic diseases, as cancer, are capable to lead to homeostasis imbalance mainly by tumor presence and the cluster of symptoms involved in this process was named cachexia. Cancer cachexia is a metabolic syndrome characterized by a marked weight loss, loss of muscle and adipose tissues and is frequently associated with anorexia and systemic inflammation. Alterations in carbohydrate metabolism are frequent in cancer cachexia, especially insulinemic alterations. In the same way, tumor presence promotes severe systemic inflammation in the host, and it was demonstrated that this is responsible for functional alterations in many organs leading to cachexia progression. However, there are no studies that correlate the role of systemic inflammation with the alterations in carbohydrate metabolism, mainly related with alterations in insulin secretion. In previous studies we demonstrated that solid Ehrlich carcinoma-bearing mice (SET) showed drastic decrease in insulin secretion, hipoinsulinemia, increase in insulin sensitivity and glucose tolerance. With these results, numerous opportunities for study appeared, among then the establishment of inflammatory response in islets. Considering the lack of studies in this area and considering the importance of proper insulin secretion and glicemic homeostasis to the survival of cancer patients, we evaluated inflammatory response components in pancreatic islets of solid Ehrlich tumor-bearing mice in order to seek consistent information about possible mechanisms involved in alterations in insulin secretion in SET group. For this, pancreatic islets of control (CTL) and SET bearing mice were analyzed 14 days after tumor inoculation for determination of the expression of the proinflammatory citokynes TNF-α, IL-1β, IFNγ, IFN-α, IL-6 e IL-8, and ...
Mestre
Wang, Sui. "The Myt1 and Ngn3 feed-forward expression loop drives pancreatic islet differentiation in the mouse." Diss., 2009. http://etd.library.vanderbilt.edu/available/etd-11262009-124114/.
Full textLi, Xiaoyan. "Metallothionein overexpression prolongs grafts survival in the early phase of pancreatic islet transplantation." 2002. http://etd.louisville.edu/data/UofL0015t2002.pdf.
Full text"Pancreatic islet renin-angiotensin system: its role in insulin secretion and in islet transplantation." 2004. http://library.cuhk.edu.hk/record=b5892115.
Full textThesis (M.Phil.)--Chinese University of Hong Kong, 2004.
Includes bibliographical references (leaves 142-157).
Abstracts in English and Chinese.
Abstract --- p.i
摘要 --- p.iii
Acknowledgements --- p.v
Table of Contents --- p.vi
List of Abreviations --- p.x
Chapter Chapter 1 --- Introduction
Chapter 1.1 --- Pancreas and its functions --- p.1
Chapter 1.1.1 --- Structure of pancreas --- p.1
Chapter 1.1.2 --- Exocrine function --- p.4
Chapter 1.1.3 --- Endocrine function --- p.7
Chapter 1.1.3.1 --- Pancreatic islet and islet cells --- p.7
Chapter 1.1.3.2 --- Regulation of insulin secretion --- p.10
Chapter 1.1.3.3 --- Mechanism for glucose-stimulated insulin release --- p.14
Chapter 1.1.3.4 --- Bi-phase response of insulin secretion --- p.16
Chapter 1.2 --- Pancreatic Renin-Angiotensin System --- p.19
Chapter 1.2.1 --- Circulating RAS and local RAS --- p.19
Chapter 1.2.2 --- RAS inhibitors --- p.25
Chapter 1.2.2.1 --- Angiotensin converting enzyme inhibitor --- p.25
Chapter 1.2.2.2 --- Non-specific Ang II receptor blocker --- p.28
Chapter 1.2.2.3 --- Specific AT1 receptor antagonist --- p.29
Chapter 1.2.2.4 --- Specific AT2 receptor antagonist --- p.30
Chapter 1.2.3 --- RAS and Pancreas --- p.30
Chapter 1.2.3.1 --- Expression and localization of pancreatic RAS --- p.30
Chapter 1.2.3.2 --- Regulation of pancreatic RAS and its clinical relevance --- p.32
Chapter 1.3 --- Islet Transplantation and RAS --- p.34
Chapter 1.3.1 --- Whole pancreas and islet transplantation --- p.34
Chapter 1.3.2 --- Problems encountered in islet transplantation --- p.36
Chapter 1.3.3 --- Potential role of RAS in islet transplantation --- p.38
Chapter 1.4 --- Diabetes Mellitus and RAS --- p.40
Chapter 1.4.1 --- Diabetes Mellitus --- p.40
Chapter 1.4.2 --- Type 1 diabetes and its animal model --- p.42
Chapter 1.4.3 --- Type 2 diabetes and its animal model --- p.44
Chapter 1.4.4 --- RAS blockade in diabetes patients --- p.46
Chapter 1.4.5 --- Potential role of RAS in Diabetes Mellitus --- p.47
Chapter 1.5 --- Aims of Study --- p.49
Chapter Chapter 2 --- Materials and Methods
Chapter 2.1 --- Experimental animals and mouse models --- p.50
Chapter 2.1.1 --- Experimental animals for islet isolation and transplantation --- p.50
Chapter 2.1.2 --- Mouse model for type 2 diabetes --- p.51
Chapter 2.2 --- Islet isolation and transplantation --- p.52
Chapter 2.2.1 --- Enzymatic islet isolation --- p.52
Chapter 2.2.2 --- Islet transplantation --- p.53
Chapter 2.3 --- Biological assay on islet functions --- p.53
Chapter 2.3.1 --- Measurement of islet insulin release --- p.53
Chapter 2.3.2 --- Measurement of islet glucose oxidation rate --- p.56
Chapter 2.3.3 --- Measurement of islet (pro)insulin biosynthesis --- p.59
Chapter 2.3.4 --- Measurement of islet total protein synthesis --- p.60
Chapter 2.4 --- Chronic losartan treatment --- p.62
Chapter 2.5 --- Perfusion experiment of transplanted islet graft --- p.62
Chapter 2.6 --- Insulin content of the islet graft --- p.63
Chapter 2.7 --- Islet graft (pro)insulin and total protein biosynthesis --- p.64
Chapter 2.8 --- Real-time RT-PCR Analysis --- p.64
Chapter 2.8.1 --- Design of primers and probes --- p.67
Chapter 2.8.2 --- Use of internal control --- p.69
Chapter 2.8.3 --- RT-PCR reaction --- p.69
Chapter 2.8.4 --- Calculation using the comparative CT method --- p.70
Chapter 2.9 --- Western Blot Analysis --- p.71
Chapter 2.10 --- Immunocytochemistry --- p.72
Chapter 2.11 --- Statistical data analysis --- p.73
Chapter Chapter 3 --- Results
Chapter 3 .1 --- Effect of Angiotensin II and Losartan on islet insulin release --- p.74
Chapter 3.1.1 --- Insulin release from normal islets --- p.74
Chapter 3.2 --- "Effect of Angiotensin II and Losartan on islet glucose oxidation rate, (pro)insulin and total protein biosynthesis" --- p.77
Chapter 3.2.1 --- Glucose oxidation rate of isolated normal islets --- p.77
Chapter 3.2.2 --- (pro)insulin and total protein biosynthesis of isolated normal islets --- p.77
Chapter 3.3 --- Regulation of RAS components in islet transplantation --- p.81
Chapter 3.3.1 --- Expression of RAS components in endogenous islets and transplanted islets --- p.81
Chapter 3.3.2 --- Localization of AT1-receptor in endogenous islets --- p.87
Chapter 3.3.3 --- Expression of AT1-receptor protein in endogenous and transplanted islets --- p.89
Chapter 3.3.4 --- Relative abundance of RAS components in kidney and liver --- p.91
Chapter 3.3.5 --- Insulin release from perfused transplanted islet graft --- p.93
Chapter 3.3.5 --- (pro)insulin and total protein biosynthesis of transplanted islet graft --- p.96
Chapter 3.4 --- Effect of Angiotensin II and losartan on diabetic islets --- p.99
Chapter 3.4.1 --- Expression of RAS components in diabetic pancreas --- p.99
Chapter 3.4.2 --- Localization of AT1 receptors in diabetic pancreas --- p.105
Chapter 3.4.3 --- Insulin release from islets of type 2 diabetic mice --- p.107
Chapter 3.4.4 --- (pro)insulin and total protein biosynthesis of islets from type 2 diabetic mice --- p.112
Chapter Chapter 4 --- Discussion
Chapter 4.1 --- Effect of angiotensin II and losartan on islet insulin release --- p.116
Chapter 4.2 --- Existence of local RAS in pancreatic islets --- p.119
Chapter 4.3 --- Regulation of islet RAS components in transplanted islets --- p.122
Chapter 4.4 --- Clinical relevance of islet RAS in transplantation --- p.125
Chapter 4.5 --- Regulation of islet RAS by type 2 diabetes --- p.126
Chapter 4.6 --- Clinical relevance of islet RAS in type 2 diabetes --- p.134
Chapter 4.7 --- Conclusion --- p.140
Chapter 4.8 --- Further studies --- p.141
Chapter Chapter 5 --- Bibliography --- p.142
Ramji, Qahir Alnasir. "Co-transplantation of neonatal porcine islets with Sertoli cells combined with short-term monoclonal antibody therapy in preventing neonatal porcine islet xenograft rejection." 2009. http://hdl.handle.net/10048/461.
Full textA thesis submitted to the Faculty of Graduate Studies and Research in partial fulfillment of the requirements for the degree of Master of Science in Experimental Surgery, Department of Surgery, University of Alberta. Title from pdf file main screen (viewed on July 28, 2009). Includes bibliographical references.
Li, Xiaoyan. "The roles of pancreatic beta cell antioxidants in islet transplantation and type 1 diabetes." 2004. http://etd.louisville.edu/data/UofL0054d2004.pdf.
Full text"The effects of neuroendocrine factors on islet cell gene expression." 1996. http://library.cuhk.edu.hk/record=b5889162.
Full textYear shown on spine: 1997.
Thesis (M.Phil.)--Chinese University of Hong Kong, 1996.
Includes bibliographical references (leaves 92-117).
Declaration --- p.i
Acknowledgements --- p.ii
Abstract --- p.iii
Table of Contents --- p.v
Chapter Chapter 1 --- Introduction --- p.1
Chapter 1.1 --- Pancreas and Islets of Langerhans --- p.1
Chapter 1.1.1 --- Islet Hormones and Glucose Balance --- p.3
Chapter 1.1.2 --- Glucagon and Its Derived Peptides --- p.4
Chapter A. --- Tissue-specific Post-translational Processing --- p.4
Chapter B. --- Features of Proglucagon Gene --- p.6
Chapter 1.1.3 --- Insulin and Features of Its Gene --- p.9
Chapter 1.2 --- Regulation of Islet Hormone Secretion --- p.12
Chapter 1.2.1 --- Endocrine Control --- p.12
Chapter A --- GIP --- p.13
Chapter B. --- Truncated GLP-1 --- p.13
Chapter 1.2.2 --- Paracrine Control --- p.14
Chapter 1.2.3 --- Neuroendocrine Control --- p.15
Chapter 1.3 --- Neuropeptide Y --- p.16
Chapter 1.3.1 --- NPY in Central Nervous System --- p.17
Chapter 1.3.2 --- NPY in Pancreas --- p.17
Chapter 1.3.3 --- NPY and Islet Hormones --- p.18
Chapter 1.4 --- Synthesis and Secretion --- p.19
Chapter 1.5 --- Objectives of Study --- p.23
Chapter Chapter 2 --- Materials and Methods --- p.26
Chapter 2.1 --- Effects of NPY on Islet Gene Expression --- p.26
Chapter 2.1.1 --- Tissue Culture --- p.26
Chapter A. --- Materials --- p.26
Chapter B. --- Maintenance and Passage --- p.26
Chapter C. --- Experimental Protocol --- p.28
Chapter 2.1.2 --- Total RNA Isolation --- p.28
Chapter A. --- Materials --- p.28
Chapter B. --- Extraction Using FastPrep System --- p.29
Chapter C. --- Quantification of RNA --- p.30
Chapter D. --- Preparation of Reagents --- p.30
Chapter 2.1.3 --- Northern Blot Analysis --- p.31
Chapter A. --- Materials --- p.31
Chapter B. --- Formaldehyde Gel Electrophoresis --- p.32
Chapter C. --- Transfer onto Nylon Membrane --- p.33
Chapter D. --- Labeling of cDNA Probes --- p.34
Chapter E. --- Hybridization and Autoradiography --- p.35
Chapter F. --- Preparation of Reagents --- p.36
Chapter 2.1.4 --- Preparation of cDNA Probe --- p.37
Chapter A. --- Materials --- p.37
Chapter B. --- Preparation of Competent Cells --- p.37
Chapter C. --- Transformation --- p.38
Chapter D. --- Plasmid DNA Isolation --- p.39
Chapter E. --- Restriction Enzyme Digestion --- p.41
Chapter F. --- Agarose Gel Electrophoresis --- p.42
Chapter G. --- Isolation of DNA Fragments --- p.42
Chapter H. --- Preparation of Reagents --- p.43
Chapter 2.1.5 --- Data Analysis --- p.46
Chapter 2.2 --- Effects of NPY on Cytosolic Calcium --- p.46
Chapter 2.2.1 --- Tissue Culture --- p.47
Chapter 2.2.2 --- Confocal Laser Scanning Microscopy --- p.47
Chapter A. --- Materials --- p.47
Chapter B. --- Loading of Dye --- p.48
Chapter C. --- Cytosolic Calcium Measurement --- p.49
Chapter D. --- Preparation of Reagents --- p.49
Chapter Chapter 3 --- Results --- p.51
Chapter 3.1 --- Studies on Islet Gene Expression --- p.51
Chapter 3.1.1 --- Effect of NPY on Proglucagon Expression --- p.51
Chapter A. --- Effect at 11 mM Glucose --- p.51
Chapter B. --- Effect at 5 mM Glucose --- p.52
Chapter 3.1.2 --- Effect of NPY on Proinsulin Expression --- p.52
Chapter 3.1.3 --- "Effect of PYY, PP and FSK on Proglucagon Expression" --- p.53
Chapter 3.2 --- Studies on Cytosolic Calcium --- p.65
Chapter 3.2.1 --- Features of InRlG9 Cells --- p.65
Chapter 3.2.2 --- Effect of NPY on Cellular Calcium Level --- p.66
Chapter Chapter 4 --- Discussion --- p.77
Chapter Chapter 5 --- References --- p.92
"The modulatory effects of simvastatin, a HMG CoA reductase inhibitor, on insulin release from isolated porcine pancreatic islets of Langerhans." 2010. http://library.cuhk.edu.hk/record=b5894451.
Full textThesis (M.Phil.)--Chinese University of Hong Kong, 2010.
Includes bibliographical references (leaves 207-251).
Abstracts in English and Chinese.
ABSTRACT --- p.i
摘要 --- p.iv
ACKNOWLEDGEMENTS --- p.vi
PUBLICATIONS BASED ON WORK IN THIS THESIS --- p.vii
ABBREVIATIONS --- p.viii
TABLE OF CONTENTS --- p.x
Chapter CHAPTER 1 --- INTRODUCTION --- p.1
Chapter 1.1 --- Diabetes Mellitus --- p.1
Chapter 1.2 --- Structure and Functions of the Pancreas --- p.2
Chapter 1.2.1 --- Size of Pancreatic β-Cells --- p.4
Chapter 1.2.2 --- Signaling Pathways of Insulin Secretion from Pancreatic β-Cells --- p.4
Chapter 1.3 --- Classification of Diabetes --- p.6
Chapter 1.3.1 --- Type 1 Diabetes --- p.6
Chapter 1.3.2 --- Type 2 Diabetes --- p.8
Chapter 1.4 --- Pathologies of Type 2 Diabetes --- p.9
Chapter 1.4.1 --- Hyperglycemia --- p.9
Chapter 1.4.1.1 --- A dvanced Glycosylation End Products --- p.11
Chapter 1.4.1.2 --- Protein Kinase C Activation --- p.13
Chapter 1.4.1.3 --- The Glucosamine Pathway --- p.14
Chapter 1.4.1.4 --- Oxidative Stress --- p.15
Chapter 1.4.2 --- Insulin Resistance --- p.15
Chapter 1.4.3 --- Loss of β-Cell Mass and β-Cell Dysfunction --- p.18
Chapter 1.5 --- Complications of Diabetes Mellitus --- p.21
Chapter 1.5.1 --- Cardiovascular Diseases --- p.21
Chapter 1.5.2 --- Diabetic Retinopathy --- p.22
Chapter 1.5.3 --- Diabetic Nephropathy --- p.23
Chapter 1.5.4 --- Neuropathy --- p.24
Chapter 1.6 --- Anti-Diabetic Drugs for Type 2 Diabetes Mellitus --- p.25
Chapter 1.6.1 --- Secretagogues --- p.25
Chapter 1.6.2 --- Sensitizers --- p.26
Chapter 1.6.3 --- Alpha-Glucosidase Inhibitors --- p.27
Chapter 1.6.4 --- Peptide Analogs --- p.27
Chapter 1.6.4.1 --- Incretin Mimetics --- p.27
Chapter 1.6.4.2 --- Dipeptidyl Peptidase-4 Inhibitors --- p.28
Chapter 1.7 --- Insights of Porcine Islets in Treatment of Diabetics --- p.28
Chapter 1.8 3 --- -Hydroxy-3-Methylglutaryl Coenzyme A Reductase (HMG CoA Reductase) --- p.31
Chapter 1.8.1 --- Statins --- p.32
Chapter 1.8.2 --- Pleiotropic Effects of Statins --- p.36
Chapter 1.8.2.1 --- Statins and Isoprenylated Proteins --- p.36
Chapter 1.8.2.2 --- Statins and Endothelial Functions --- p.38
Chapter 1.8.2.3 --- Statins and Platelet Functions --- p.39
Chapter 1.8.2.4 --- Statins and Plaque Stability --- p.39
Chapter 1.8.2.5 --- Statins and Vascular Inflammation --- p.40
Chapter 1.9 --- Clinical Studies of Statins on Diabetics --- p.41
Chapter 1.10 --- Possible Factors Involved in Simvastatin-Regulated Insulin Secretion --- p.44
Chapter 1.10.1 --- AMP-Activated Protein Kinase --- p.44
Chapter 1.10.2 --- Caveolin-1 --- p.46
Chapter 1.10.3 --- Sterol-Regulatory Elementary Binding Protein --- p.50
Chapter 1.10.4 --- Protein Phosphatase 2A --- p.52
Chapter 1.10.5 --- Calcium Sensing Receptor --- p.55
Chapter 1.11 --- Objectives of Study --- p.59
Chapter CHAPTER 2 --- MATERIALS AND METHODS --- p.60
Chapter 2.1 --- Materials --- p.60
Chapter 2.1.1 --- Solutions --- p.60
Chapter 2.1.2 --- Antibodies --- p.63
Chapter 2.2 --- Methods --- p.64
Chapter 2.2.1 --- Maintenance of Pancreas Function --- p.64
Chapter 2.2.2 --- Islet Isolation --- p.65
Chapter 2.2.3 --- Hematoxylin and Eosin (H&E) Staining --- p.65
Chapter 2.2.4 --- Simvastatin and Simvastatin-Na+ --- p.66
Chapter 2.2.5 --- AICAR --- p.67
Chapter 2.2.6 --- Compound C --- p.67
Chapter 2.2.7 --- Incubation of Islets --- p.67
Chapter 2.2.8 --- Western Blot --- p.68
Chapter 2.2.9 --- Enzyme-Linked Immunosorbent Assay (ELISA) --- p.69
Chapter 2.2.10 --- Statistical Analysis --- p.71
Chapter CHAPTER 3 --- HISTOLOGY OF PORCINE PANCREATIC ISLETS OF LANGERHANS --- p.72
Chapter 3.1 --- Comparison of Sizes of Porcine Pancreatic Islets in Histological Sections of Pancreas --- p.72
Chapter CHAPTER 4 --- PROTEIN EXPRESSION OF HMG COA REDUCTASE --- p.75
Chapter 4.1 --- Effect of Incubation Time on HMG CoA Reductase Expression --- p.75
Chapter 4.2 --- Short-Term Effect of Simvastatin on HMG CoA Reductase Expression --- p.78
Chapter 4.3 --- Long-Term Effect of Simvastatin on HMG CoA Reductase Expression --- p.81
Chapter 4.4 --- Effect of Osmolality on HMG CoA Reductase Expression --- p.83
Chapter 4.5 --- Effect of Simvastatin on Ser871 p-HMG CoA Reductase Expression --- p.87
Chapter CHAPTER 5 --- EVALUATION OF THE ROLE OF SIMVASTATIN IN INSULIN SECRETION VIA HMG CO A REDUCTASE REGULATION --- p.90
Chapter 5.1 --- Effect of Simvastatin on Insulin Secretion --- p.90
Chapter 5.2 --- Effect of Different Concentrations of Simvastatin on Insulin Secretion --- p.94
Chapter 5.3 --- Effect of Simvastatin on Insulin Content --- p.96
Chapter CHAPTER 6 --- ROLE OF AMPK EXPRESSION IN INSULIN SECRETION PATHWAY --- p.100
Chapter 6.1 --- Effect of Simvastatin on Thr172 p-AMPK α and AMPK α1 Expressions --- p.100
Chapter 6.2 --- Evaluation of the Role of Simvastatin in AMPK Regulation --- p.104
Chapter 6.3 --- Evaluation of the Role of PP2A in AMPK Regulation --- p.108
Chapter 6.4 --- Evaluation of the Role of Simvastatin on Insulin Secretion via AMPK Regulation --- p.111
Chapter 6.4.1 --- AMPK Regulation on Releasable Insulin Secretion --- p.111
Chapter 6.4.2 --- AMPK Regulation on Non-Releasable Insulin Content and Total Insulin Content --- p.112
Chapter CHAPTER 7 --- EFFECT OF SIMVASTATIN ON THE EXPRESSION OF REGULATORY PROTEINS INVOLVED IN INSULIN SECRETION --- p.119
Chapter 7.1 --- Effect of Simvastatin on SREBP-2 Expression --- p.119
Chapter 7.2 --- Effect of Simvastatin on Caveolin-1 Expression --- p.121
Chapter 7.3 --- Effect of Simvastatin on Calcium Sensing Receptor Expression --- p.123
Chapter CHAPTER 8 --- EFFECT OF SIMVASTATIN-NA+ ON INSULIN SECRETION --- p.126
Chapter 8.1 --- Effect of Simvastatin-Na+ on HMG CoA Reductase Expression --- p.126
Chapter 8.2 --- Effect of Simvastatin-Na+ on Insulin Secretion --- p.128
Chapter 8.3 --- Effect of Different Concentrations of Simvastatin-Na+ on Insulin Secretion --- p.130
Chapter 8.4 --- Effect of Simvastatin-Na+ on Insulin Content --- p.132
Chapter CHAPTER 9 --- EFFECT OF PRAVASTATIN ON INSULIN SECRETION --- p.136
Chapter 9.1 --- Effect of Pravastatin on Insulin Secretion --- p.136
Chapter 9.2 --- Effect of Pravastatin on Insulin Content --- p.138
Chapter CHAPTER 10 --- EFFECT OF METHYL-B-CYCLODEXTRIN ON INSULIN SECRETION --- p.142
Chapter 10.1 --- Effect of Methyl-β-cyclodextrin on Insulin Secretion --- p.142
Chapter 10.2 --- Effect of Methyl-β-cyclodextrin on Insulin Content --- p.144
Chapter CHAPTER 11 --- DISCUSSION --- p.149
Chapter 11.1 --- Importance of Studying Porcine Pancreatic Islets and Islet Distribution --- p.150
Chapter 11.2 --- Screening of Concentration and Incubation Time of Simvastatin on Porcine Pancreatic Islets --- p.152
Chapter 11.3 --- Glucose-Independent Effect of Simvastatin on Protein Expression of HMG CoA Reductase --- p.154
Chapter 11.4 --- Role of AMPK in HMG CoA Reductase-Modulated Insulin Secretion --- p.159
Chapter 11.5 --- Role of SREBP-2 in Simvastatin-Modulated Regulation --- p.174
Chapter 11.6 --- Role of Calcium Sensing Receptor in Simvastatin-Modulated Regulation --- p.175
Chapter 11.7 --- Role of Caveolin-1 in Simvastatin-Modulated Regulation --- p.179
Chapter 11.8 --- "Effects of Simvastatin-Na+, Pravastatin and Methyl-β-cyclodextrin, and Importance of Endoplasmic Reticulum in Insulin Secretion" --- p.183
Chapter CHAPTER 12 --- CONCLUSIONS AND FURTHER STUDIES --- p.197
Chapter 12.1 --- Conclusions --- p.197
Chapter 12.2 --- Further Studies --- p.203
REFERENCES --- p.207
Millings, Elizabeth Joy. "Investigating the Role of ILDR2 in Hepatic Lipid Metabolism and Pancreas Islet Function." Thesis, 2017. https://doi.org/10.7916/D8NS169R.
Full textSinger, Ruth Arielah. "Long noncoding RNAs are critical regulators of pancreatic islet development and function." Thesis, 2019. https://doi.org/10.7916/d8-nnax-mb40.
Full text"Studies on some factors critical for the development of pancreatic progenitor cells derived from human fetal pancreas." 2011. http://library.cuhk.edu.hk/record=b5896938.
Full textThesis (M.Phil.)--Chinese University of Hong Kong, 2011.
Includes bibliographical references (leaves 179-204).
Abstracts in English and Chinese.
Abstract --- p.I
摘要 --- p.IV
Publications --- p.VII
Acknowledgements --- p.VIII
Table of contents --- p.IX
List of figures --- p.XV
List of tables --- p.XVII
List of abbreviations --- p.XVIII
Chapter Chapter 1 --- General Introduction
Chapter 1.1 --- The Pancreas --- p.2
Chapter 1.1.1 --- Anatomy of Pancreas --- p.2
Chapter 1.1.2 --- The Exocrine Pancreas --- p.4
Chapter 1.1.3 --- The Endocrine Pancreas --- p.5
Chapter 1.1.3.1 --- Structure of Islets --- p.5
Chapter 1.1.3.2 --- "Functions of α-, β-, y-, ð-, Σ-and PP-cells in Islets" --- p.7
Chapter 1.1.4 --- Overview of Pancreas Development --- p.9
Chapter 1.1.4.1 --- Organ Morphology --- p.10
Chapter 1.1.4.2 --- Cyto-differentiation --- p.12
Chapter 1.1.4.3 --- Control by Transcriptional Factors --- p.14
Chapter 1.1.5 --- Postnatal Pancreas Development and Regeneration --- p.18
Chapter 1.1.5.1 --- Proliferation of Pre-existing β-cells --- p.19
Chapter 1.1.5.2 --- Neogenesis from Precursor Cells --- p.20
Chapter 1.1.5.3 --- Transdifferentiation of other Cells --- p.20
Chapter 1.2 --- Diabetes Mellitus --- p.22
Chapter 1.2.1 --- Pathophysiology of Diabetes Mellitus and Current Treatments --- p.24
Chapter 1.2.1.1 --- Type I Diabetes Mellitus --- p.24
Chapter 1.2.1.2 --- Type II Diabetes Mellitus --- p.25
Chapter 1.2.1.3 --- Gestational Diabetes --- p.27
Chapter 1.2.1.4 --- Secondary Diabetes --- p.28
Chapter 1.3 --- Stem Cell therapy --- p.29
Chapter 1.3.1 --- Stem Cell --- p.29
Chapter 1.3.1.1 --- Mesenchymal Stem Sell --- p.31
Chapter 1.3.1.2 --- Embryonic Stem Cell --- p.35
Chapter 1.3.1.3 --- Induced Pluripotent Stem Cell --- p.36
Chapter 1.3.2 --- Islets Engineering --- p.37
Chapter 1.3.2.1 --- Genetic Modification --- p.37
Chapter 1.3.2.2 --- Directed Differentiation --- p.38
Chapter 1.3.2.3 --- Microenvironment --- p.38
Chapter 1.3.2.4 --- In vivo Regeneration --- p.39
Chapter 1.3.2.5 --- Cell Fusions --- p.40
Chapter 1.3.2.6 --- Combinatory Treatments --- p.40
Chapter 1.4 --- The Vitamin A & Vitamin D System --- p.42
Chapter 1.4.1 --- The Vitamin A --- p.42
Chapter 1.4.2 --- Vitamin A Metabolism --- p.44
Chapter 1.4.3 --- Roles of vitamin A in Pancreatic Development --- p.46
Chapter 1.4.4 --- The Vitamin D --- p.48
Chapter 1.4.5 --- Vitamin D Metabolism --- p.49
Chapter 1.4.6 --- Metabolic Functions of Vitamin D in Islets --- p.51
Chapter 1.4.7 --- Cod Liver Oil --- p.53
Chapter 1.4.8 --- Interactions between Vitamin A and Vitamin D --- p.53
Chapter 1.5 --- The Relations of Liver and Pancreas Development --- p.55
Chapter 1.5.1 --- Endoderm Induction for Hepatic and Pancreatic Differentiation of ESCs --- p.55
Chapter 1.5.2 --- Bipotential Precursor Population within Embryonic Endoderm --- p.56
Chapter 1.5.3 --- Pancreatic Islets Promote Mature Liver Hepatocytes Proliferation --- p.57
Chapter 1.5.4 --- Transdifferentiation --- p.57
Chapter 1.5.5 --- Transplantation in Liver Niche Promotes Maturation of Insulin-Producing Cells --- p.60
Chapter 1.5.6 --- Neuronal Relay from the Liver to Pancreatic --- p.61
Chapter 1.5.7 --- Development of Islets in the Nile Tilapia --- p.62
Chapter 1.6 --- The Insulin-like Growth Factor-I (IGF1) --- p.64
Chapter 1.6.1 --- IGF1 System --- p.64
Chapter 1.6.2 --- IGF 1 Regulation --- p.65
Chapter 1.6.3 --- Roles of IGF 1 in Pancreatic Development and Regeneration --- p.68
Chapter 1.7 --- Aims and Objectives of Study --- p.70
Chapter Chapter 2 --- General Materials and Methods
Chapter 2.1 --- Pancreatic progenitor cells (PPCs) and liver stromal cells (LSCs) isolation and cell culture --- p.72
Chapter 2.1.1 --- Tissue procurement --- p.72
Chapter 2.1.2 --- PPC and LSC culture --- p.72
Chapter 2.1.3 --- "Treatments of vitamin A, vitamin D and IGF 1" --- p.76
Chapter 2.1.4 --- "Cell culture of Caco-2, HepG2 and DU-145" --- p.76
Chapter 2.2 --- Induction of Islet-like Cell Clusters (ICCs) Differentiation --- p.77
Chapter 2.2.1 --- In vitro Directed Differentiation --- p.77
Chapter 2.2.2 --- In vitro LSC Microenvironment --- p.77
Chapter 2.3 --- RNA Expression Detection --- p.79
Chapter 2.3.1 --- RNA isolation --- p.79
Chapter 2.3.2 --- Reverse Transcription --- p.79
Chapter 2.3.3 --- Polymerase Chain Reaction (PCR) --- p.80
Chapter 2.3.4 --- Realtime PCR --- p.81
Chapter 2.4 --- Immunocytochemistry --- p.83
Chapter 2.5 --- Western Blotting --- p.85
Chapter 2.5.1 --- Protein extraction and quantification --- p.85
Chapter 2.5.2 --- Western Blotting --- p.85
Chapter 2.6 --- Enzyme-linked Immunosorbent Assay (ELISA) --- p.87
Chapter 2.6.1 --- Detection of cell viability --- p.87
Chapter 2.6.2 --- Detection of cell proliferation --- p.87
Chapter 2.6.3 --- Measurement of Cell death --- p.88
Chapter 2.6.4 --- Measurement of IGF 1 level in condition medium --- p.89
Chapter 2.6.5 --- Measurement of glucose induced insulin secretion --- p.90
Chapter 2.7 --- Regeneration model --- p.92
Chapter 2.7.1 --- Regeneration model in neonatal-STZ rat --- p.92
Chapter 2.7.2 --- Change in IGF1 expression in pancreas and liver --- p.92
Chapter 2.8 --- Statistical Data Analysis --- p.93
Chapter Chapter 3 --- Vitamin D and vitamin A receptor expression and the proliferative effects of ligand activation of these receptors on the development of pancreatic progenitor cells derived from human fetal pancreas. (Stem Cell Rev. 2011;7:53-63)
Chapter 3.1 --- Abstract --- p.95
Chapter 3.2 --- Introduction --- p.97
Chapter 3.3 --- Materials and Methods --- p.101
Chapter 3.3.1 --- Fetal Tissue Procurement --- p.101
Chapter 3.3.2 --- Culture of Pancreatic Progenitor Cells --- p.101
Chapter 3.3.3 --- RNA Expression Analysis by Reverse Transcription-Polymerase Chain Reaction (RT-PCR) --- p.102
Chapter 3.3.4 --- Western Blot Analysis --- p.103
Chapter 3.3.5 --- Immunocytochemstry --- p.105
Chapter 3.3.6 --- PPC Proliferation Assays --- p.106
Chapter 3.3.7 --- PPC Cell Death Assays --- p.107
Chapter 3.3.8 --- Statistical Data Analysis --- p.108
Chapter 3.4 --- Results --- p.110
Chapter 3.4.1 --- "Expression and Localization of RAR, VDR and RXR, CYP26 and CYP24 in PPCs" --- p.110
Chapter 3.4.2 --- Incubation of PPC with atRA Enhances PPC Viability due to Increased Proliferation and Anti-apoptosis --- p.111
Chapter 3.4.3 --- Incubation of PPCs with Calcitriol Enhances Viability due to Increased Proliferation --- p.111
Chapter 3.4.4 --- Both atRA and Calcitriol Induce Up-regulation of both the RAR and the VDR but not the RXR --- p.112
Chapter 3.4.5 --- Combination Treatment with atRA and Calcitriol on Cell Viability and NGN3 Expression --- p.112
Chapter 3.5 --- Discussion --- p.114
Chapter Chapter 4 --- Human fetal liver stromal cell co-culture enhances the growth and differentiation of pancreatic progenitor cells into islet-like cell clusters (In submission to Gastroenterology)
Chapter 4.1 --- Abstract --- p.128
Chapter 4.2 --- Introduction --- p.129
Chapter 4.3 --- Materials and Methods --- p.133
Chapter 4.3.1 --- Use of human and animal tissues --- p.133
Chapter 4.3.2 --- "Cell preparation, characterizations and Differentiation" --- p.133
Chapter 4.3.3 --- Examination of PPC growth and ICC differentiation and functions with LSC co-culture --- p.133
Chapter 4.3.3 --- Identification of growth factors and investigation of their effects --- p.134
Chapter 4.3.4 --- Statistical Analysis --- p.135
Chapter 4.4 --- Results --- p.136
Chapter 4.4.1 --- "Isolation, Culture and Characterizations of LSCs" --- p.136
Chapter 4.4.2 --- Establishment of LSC co-culture system --- p.136
Chapter 4.4.3 --- LSC co-culture enhances PPC-derived ICC differentiation --- p.137
Chapter 4.4.4 --- Differential expression of mRNA for cytokines and growth factors between 1st and 2nd trimester LSCs --- p.138
Chapter 4.4.5 --- Characterization of IGF 1 receptors in PPCs and the effects of exogenous IGF1 on PPC growth and ICC differentiation --- p.139
Chapter 4.4.6 --- Neutralizing antibodies against IGF1R inhibit ICC differentiation --- p.140
Chapter 4.5 --- Discussion --- p.142
Chapter 4.6 --- Supplementary Materials and Methods --- p.147
Chapter 4.6.1 --- Cell Preparation and culture --- p.147
Chapter 4.6.2 --- In Vitro ICC differentiation --- p.148
Chapter 4.6.3 --- RNA expression analysis --- p.149
Chapter 4.6.4 --- Immunocytochemistry --- p.149
Chapter 4.6.5 --- PPC viability and cell count assays --- p.150
Chapter 4.6.6 --- IGF1 and insulin ELISA --- p.151
Chapter 4.6.7 --- Western blotting analysis --- p.152
Chapter 4.6.8 --- Neonatal streptozotocin regeneration model --- p.153
Chapter Chapter 5 --- General Discussion and Future Studies
Chapter 5.1 --- General Discussion --- p.165
Chapter 5.1.1 --- Proliferative effects and enhance expression of NGN3 by vitamin A and vitamin D on PPC --- p.166
Chapter 5.1.2 --- Induction of PPC derived ICCs by LSCs --- p.169
Chapter 5.1.3 --- Potential effects of liver stroma derived IGF1 on PPC derived ICCs differentiation --- p.172
Chapter 5.1.4 --- Significance of islet engineering in the management of diabetes --- p.174
Chapter 5.1.5 --- Conclusions --- p.176
Chapter 5.2 --- Future Studies --- p.177
Chapter Chapter 6 --- Reference
Reference --- p.180
"Isolation, characterization and differentiation of pancreatic progenitor cells from human fetal pancreas." Thesis, 2007. http://library.cuhk.edu.hk/record=b6074338.
Full textDue to the scarcity of fetal pancreas for generating functional insulin-secreting cell clusters for sufficient islet transplantation, we targeted for searching pancreatic stem/progenitor cells. Putative PSCs can be aggregated and differentiated into islet-like cell clusters (ICCs) when exposed to serum-free medium containing various conventional growth factors, including HGF, GLP-1, betacellulin and nicotinamide.
Fetal pancreatic tissue consisting of immature progenitor cells serves as a potential source of stem cells as they possess a higher replicative capacity and longevity than their adult counterparts.
Two novel candidates and a key pancreatic transcription factor on the PSC/ICC proliferation and differentiation were investigated in the present study. One of them is a ubiquitously expressed multi-PDZ-domain protein, PDZ-domain-containing 2 (PDZD2), which was previously found to express in the mouse beta cells and exhibit mitogenic effects in beta cell line. Results showed that PDZD2 was detected in high levels in both human fetal pancreas and in PSCs. Results indicate the potential involvement of PDZD2 in regulating PSCs proliferation and differentiation and pancreatic development.
Suen Po Man, Ada.
"July 2007."
Adviser: P.S. Leung.
Source: Dissertation Abstracts International, Volume: 69-01, Section: B, page: 0051.
Thesis (Ph.D.)--Chinese University of Hong Kong, 2007.
Includes bibliographical references (p. 194-214).
Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web.
Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [200-] System requirements: Adobe Acrobat Reader. Available via World Wide Web.
Abstracts in English and Chinese.
School code: 1307.
"Studies on some immune properties of the pancreatic progenitor cells derived from human fetal pancreas." 2010. http://library.cuhk.edu.hk/record=b5894466.
Full text"July 2010."
Thesis (M.Phil.)--Chinese University of Hong Kong, 2010.
Includes bibliographical references (leaves 186-207).
Abstracts in English and Chinese.
Abstract --- p.I
List of Publications --- p.VI
Acknowledgements --- p.VIII
Table of Contents --- p.X
List of Figures --- p.XV
List of Tables --- p.XVIII
List of Abbreviations --- p.XIX
Chapter CHAPTER1 --- INTRODUCTION
Chapter 1.1 --- The Pancreas --- p.2
Chapter 1.1.1 --- Structure of pancreas --- p.2
Chapter 1.1.2 --- Structure and function of exocrine pancreas --- p.6
Chapter 1.1.3 --- Structure and function of endocrine pancreas --- p.9
Chapter 1.1.3.1 --- Pancreatic islet and islet cells --- p.9
Chapter 1.1.3.2 --- Glucose-stimulated insulin secretion from islets --- p.12
Chapter 1.2 --- Type 1 Diabetes Mellitus (T1DM) --- p.14
Chapter 1.2.1 --- Pathophysiology of Diabetes Mellitus --- p.14
Chapter 1.2.2 --- Autoimmunity in T1DM --- p.17
Chapter 1.2.3 --- Management ofTlDM --- p.20
Chapter 1.2.3.1 --- Insulin replacement --- p.20
Chapter 1.2.3.2 --- Pancreas and islet transplantation --- p.21
Chapter 1.2.3.3 --- Stem-cell-based transplantation --- p.22
Chapter 1.3 --- The Adaptive Immune System --- p.26
Chapter 1.3.1 --- T-lymphocytes --- p.26
Chapter 1.3.2 --- B-lymphocytes --- p.29
Chapter 1.3.3 --- Major histocompatibility complex (MHC) --- p.30
Chapter 1.3.3.1 --- Classification of MHC molecules --- p.30
Chapter 1.3.3.2 --- Structure of MHC class I and II molecules --- p.32
Chapter 1.3.3.3 --- Function and regulation of MHC molecules --- p.34
Chapter 1.3.4 --- HLA-G and its immuno-modulatory properties --- p.36
Chapter 1.4 --- Transplantation Rejection --- p.40
Chapter 1.4.1 --- Mechanisms involved in transplantation rejection --- p.40
Chapter 1.4.2 --- Immunobiology of rejection --- p.41
Chapter 1.4.2.1 --- Direct allorecognition pathway --- p.42
Chapter 1.4.2.2 --- Indirect allorecognition pathway --- p.43
Chapter 1.4.2.3 --- Semi-direct allorecognition pathway --- p.43
Chapter 1.4.3 --- Xenotransplantation --- p.46
Chapter 1.5 --- Cytokines and Immunity --- p.48
Chapter 1.5.1 --- Interferons --- p.48
Chapter 1.5.1.1 --- Interferon-γ and its immune regulation --- p.49
Chapter 1.5.1.2 --- Effect and kinetics of interferon-γ on MHC molecules expression --- p.53
Chapter 1.5.1.3 --- Regulation of interferon-γ production --- p.56
Chapter 1.5.2 --- Interlukins --- p.58
Chapter 1.5.2.1 --- IL-10 and its immune regulation --- p.58
Chapter 1.5.2.2 --- IL-10 and HLA-G --- p.59
Chapter 1.6 --- Stem Cells and their Immunogenicity --- p.62
Chapter 1.6.1 --- Embroynic stem cells --- p.62
Chapter 1.6.2 --- Mesenchymal stem cells --- p.64
Chapter 1.6.3 --- Neural stem cells --- p.68
Chapter 1.6.4 --- Fetal stem cells --- p.69
Chapter 1.6.5 --- Potential immuno-study in human fetal pancreatic stem cells --- p.70
Chapter 1.7 --- Aims and Objectives of study --- p.72
Chapter CHAPTER2 --- MATERIALS AND METHODS
Chapter 2.1 --- Isolation of Pancreatic Progenitors (PPCs) from Human Fetal Pancreas and Induction of Islet-like Cell Cluster (ICCs) Differentiation --- p.75
Chapter 2.1.1 --- Tissue procurement --- p.75
Chapter 2.1.2 --- Tissue processing and PPCs culture --- p.75
Chapter 2.1.3 --- In vitro differentiation of PPCs into ICCs --- p.78
Chapter 2.1.4 --- Interferon-γ and IL-10 treatment --- p.80
Chapter 2.2 --- Cell culture of human placental Choriocarcinoma JEG-3 Cell Line --- p.81
Chapter 2.3 --- RNA Expression Detection --- p.82
Chapter 2.3.1 --- RNA isolation --- p.82
Chapter 2.3.2 --- Reverse transcriptase (RT) --- p.83
Chapter 2.3.3 --- Design of primers for Polymerase Chain Reaction (PCR) and Real-time PCR --- p.84
Chapter 2.3.4 --- PCR --- p.86
Chapter 2.3.5 --- Real-time PCR analysis --- p.88
Chapter 2.3.6 --- Calculation using the comparative CT method --- p.90
Chapter 2.4 --- Flow Cytometry --- p.91
Chapter 2.5 --- Western Blotting Analysis --- p.93
Chapter 2.5.1 --- Protein extraction and quantification --- p.93
Chapter 2.5.2 --- Western blotting --- p.93
Chapter 2.6 --- Mixed Lymphocyte Reaction (MLR) --- p.95
Chapter 2.6.1 --- Isolation of peripheral blood mononuclear cells (PBMCs) --- p.95
Chapter 2.6.2 --- PPC-PBMCs MLR --- p.98
Chapter 2.6.3 --- ICC-PBMCs MLR --- p.98
Chapter 2.6.4 --- Proliferation assay --- p.99
Chapter 2.7 --- ICC Transplantation --- p.101
Chapter 2.7.1 --- Streptozotocin-induced diabetic animals for transplantation --- p.101
Chapter 2.7.2 --- Procedures of ICCs transplantation --- p.102
Chapter 2.8 --- Histological Analysis of ICC Graft --- p.105
Chapter 2.8.1 --- H&E staining --- p.105
Chapter 2.8.2 --- DAB staining --- p.106
Chapter 2.8.3 --- Immunofluorescence staining --- p.107
Chapter 2.9 --- Enzyme-linked Immunosorbent Assay (ELISA) --- p.109
Chapter 2.10 --- Statistical Data Analysis --- p.110
Chapter CHAPTER3 --- RESULTS
Chapter 3.1 --- Immuno-characterization of PPCs and ICCs --- p.112
Chapter 3.2 --- Effect of cytokines on immune-properties of PPCs and ICCs --- p.115
Chapter 3.2.1 --- Effect of lFN-γ on MHC-I expression in PPCs --- p.115
Chapter 3.2.2 --- Effect of lFN-γ and IL-10 on HLA-G expression in PPCs and ICCs --- p.119
Chapter 3.2.3 --- Effect of IFN-γ on B7H4 expression in PPCs --- p.123
Chapter 3.3 --- Comparison of immune-properties of PPCs and ICCs from 1st and 2nd trimester --- p.125
Chapter 3.3.1 --- Differential expression of MHC molecules in PPCs --- p.125
Chapter 3.3.2 --- Different immune-related gene expression in PPCs and ICCs --- p.128
Chapter 3.3.3 --- Comparison of IFN-γ activated MHC molecules expression in PPCs/ICCs --- p.134
Chapter 3.3.4 --- Comparison of other IFN-γ activated genes expression in PPCs --- p.139
Chapter 3.4 --- Mixed lymphocyte reaction of PPCs from 1st and 2nd trimester --- p.143
Chapter 3.4.1 --- Effect of PPCs on proliferation of PBMC --- p.143
Chapter 3.4.2 --- Effect of ICCs on proliferation of PBMC --- p.145
Chapter 3.4.3 --- Effect of PPCs on cytokine production in PBMC --- p.149
Chapter 3.5 --- Xenotransplantation of ICCs into diabetic mouse model --- p.152
Chapter 3.5.1 --- Blood glucose level of diabetic mice after transplantation --- p.152
Chapter 3.5.2 --- Histological evaluation of transplanted ICCs grafts --- p.154
Chapter 3.5.3 --- Infiltration of CD45 into transplanted grafts of 1st and 2nd trimester --- p.158
Chapter CHAPTER4 --- DISCUSSION
Chapter 4.1 --- Expression of selected immuno-regulated genes in PPCs and ICCs --- p.163
Chapter 4.2 --- Effect of IFN-g and IL-10 on expression of immuno-regulated genes in PPCs and ICCs --- p.166
Chapter 4.3 --- In vitro studies on immunogenicity of PPCs and ICCs from first and second trimester --- p.171
Chapter 4.3.1 --- Immune-related genes expression --- p.171
Chapter 4.3.2 --- IFN-γ activated gene expression --- p.173
Chapter 4.3.3 --- Mixed lymphocyte reaction --- p.175
Chapter 4.3.4 --- Cytokine production of PBMC in MLR --- p.179
Chapter 4.4 --- In vivo Xenotransplantation of ICCs into diabetic mouse model --- p.181
Chapter 4.5 --- Conclusion --- p.187
Chapter 4.6 --- Further studies --- p.188
Chapter CHAPTER5 --- BIBLIOGRAPHY
Bibliography by Alphabetical Order --- p.189
Dean, Sophia Katrina Prince of Wales Clinical School UNSW. "Transplantation of fetal pig islet-like cell clusters as therapy for diabetes." 2007. http://handle.unsw.edu.au/1959.4/40870.
Full textChurchill, Angela Josephine. "Spatiotemporal and Mechanistic Analysis of Nkx2.2 Function in the Pancreatic Islet." Thesis, 2016. https://doi.org/10.7916/D84M94N2.
Full text"Ability of [beta]-cell function tests and autoimmune markers to clarify the type of diabetes in adult patients." Malmö : Dept. of Medicine, University of Lund, Malmö General Hospital, 1994. http://books.google.com/books?id=jNlqAAAAMAAJ.
Full text